Single nucleotide polymorphism (SNP) markers for stevia

ABSTRACT

Stevia  varieties with high a content of RebD, a high content of RebM, and a high content of RebD and RebM containing various SNP markers and UGT isoforms, are disclosed. Methods of screening for the SNPs are also disclosed as well as for using the SNPs in marker assisted breeding. Further provided are methods for introgressing the disclosed SNPs associated with high RebD and high RebM into  stevia  plants by selecting plants comprising for one or more SNPs and breeding with such plants to confer such desirable agronomic phenotypes to plant progeny.

CROSS REFERENCE TO RELATED APPLICATION

This application is a non-provisional patent application of and claims the benefit of priority to: PCT Application No. PCT/US2015/52366, as filed on Sep. 25, 2015; U.S. Provisional Application No. 62/116,893, filed Feb. 16, 2015; Chinese Patent Application No. 201510036580.4, filed on Jan. 23, 2015; Chinese Patent Application No. 201510037435.8, filed on Jan. 23, 2015; Chinese Patent Application No. 201510036668.6, filed on Jan. 23, 2015; U.S. Provisional Patent Application No. 62/064,601, filed on Oct. 16, 2014; U.S. Provisional Application No. 62/071,567, filed on Sep. 26, 2014; U.S. Provisional Application No. 62/071,566, filed on Sep. 26, 2014; and U.S. Provisional Application No. 62/071,568, filed on Sep. 26, 2014; the entire contents of which are incorporated herein by reference for all purposes.

SUBMISSION OF SEQUENCE LISTING

The Sequence Listing associated with this application is filed in electronic format via EFS-Web and is hereby incorporated by reference into the specification in its entirety.

BACKGROUND

Stevia is an important and valuable field crop for the production of sweeteners, sugar substitutes, and other consumable ingredients. Thus, a continuing goal of stevia plant breeders is to develop stable, high yielding stevia cultivars of stevia species that are agronomically sound. The reasons for this goal are to maximize the amount and quality of the sweeteners, sugar substitutes, and other consumable ingredients. To accomplish this goal, the stevia breeder must select and develop plants that have the traits that result in superior cultivars.

The development of new stevia cultivars requires the evaluation and selection of parents and the crossing of these parents. The lack of predictable success of a given cross requires that a breeder, in any given year, make several crosses with the same or different breeding objectives.

The foregoing examples of the related art and limitations related therewith are intended to be illustrative and not exclusive. Other limitations of the related art will become apparent to those of skill in the art upon a reading of the specification

SUMMARY

The following embodiments and aspects thereof are described and illustrated in conjunction with products and methods, which are meant to be exemplary and illustrative, not limiting in scope. In various embodiments, one or more of the above-described problems have been reduced or eliminated, while other embodiments are directed to other improvements.

The present disclosure provides a stevia plant comprising the following single nucleotide polymorphisms (SNPs), wherein said SNPs are found in homozygous form: SNP2, which comprises a G to C nucleotide substitution at position number 225 in SEQ ID NO:1, SNP10, which comprises a G to A nucleotide substitution at position number 187 in SEQ ID NO:2, SNP12, which comprises an C to T nucleotide exchange at position number 345 in SEQ ID NO:3, SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, SNP20, which comprises a G to A nucleotide substitution at position number 221 in SEQ ID NO:6, SNP22, which comprises a T to G nucleotide substitution at position number 160 in SEQ ID NO:7, and SNP24, which comprises a G to A nucleotide substitution at position number 325 in SEQ ID NO:8.

Another embodiment discloses a stevia plant, wherein the leaves of said stevia plant have a rebaudioside D/total steviol glycoside percentage between 8% and 38% and a rebaudioside M/total steviol glycoside percentage between 0% and 14% and further comprise the following SNPs in homozygous form: SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, and SNP 20, which comprises a G to A nucleotide substitution at position number 221 in in SEQ ID NO:6.

Another embodiment discloses a method for producing a stevia plant having a high rebaudioside D and high rebaudioside M content, said method comprising: (a) screening a population of stevia plants for at least one of the following SNPs: SNP2, which comprises a G to C nucleotide substitution at position number 225 in SEQ ID NO:1, SNP10, which comprises a G to A nucleotide substitution at position number 187 in SEQ ID NO:2, SNP12, which comprises an C to T nucleotide exchange at position number 345 in SEQ ID NO:3, SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, SNP20, which comprises a G to A nucleotide substitution at position number 221 in SEQ ID NO:6, SNP22, which comprises a T to G nucleotide substitution at position number 160 in SEQ ID NO:7, and SNP24, which comprises a G to A nucleotide substitution at position number 325 in SEQ ID NO:8; (b) selecting a first stevia plant having at least one said SNP; (c) crossing said first selected stevia plant having at least one said SNP with a second stevia plant having at least one said SNP; (d) repeating steps (b) and (c) to obtain stevia plants homozygous for all said SNPs; and (e) screening said stevia plants homozygous for all said SNPs to confirm the presence of all said SNPs in homozygous form to produce a stevia plant, wherein the leaves of said stevia plant have a high rebaudioside D content, high rebaudioside M content, or a high rebaudioside D and high rebaudioside M content.

BRIEF DESCRIPTION OF THE SEQUENCE LISTINGS

SEQ ID NO: 1 discloses the CC genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_5090958) and identified as SNP2.

SEQ ID NO: 2 discloses the AA genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_3488333) and identified as SNP10.

SEQ ID NO: 3 discloses the TT genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_4414800) and identified as SNP12.

SEQ ID NO: 4 discloses the CC genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_6262256) and identified as SNP17.

SEQ ID NO: 5 discloses the TT genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_6645712) and identified as SNP19.

SEQ ID NO: 6 discloses the AA genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_6647386) and identified as SNP20.

SEQ ID NO: 7 discloses the GG genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_4704641) and identified as SNP22.

SEQ ID NO: 8 discloses the AA genotype (homozygous recessive) for all RebD, and RebM lines (stv_snp_5387123) and identified as SNP24.

SEQ ID NO: 9 discloses UGT76G1 isoform sequence for 814011 (Ref_Stevia_Transcript_185827_2127).

SEQ ID NO: 10 discloses UGT76G1 isoform sequence for 814011 (Ref_Stevia_Transcript_185828_2195).

SEQ ID NO: 11 discloses UGT76G1 isoform sequence for 814011 (Ref_Stevia_Transcript_185829_807).

SEQ ID NO: 12 discloses UGT76G1 isoform sequence for 814011 (Ref_Stevia_Transcript_185830_799).

SEQ ID NO: 13 discloses UGT76G1 isoform sequence for 814011 (Ref_Stevia_Transcript_185831_875).

SEQ ID NO: 14 discloses UGT76G1 isoform sequence for 807086 (Ref_Stevia_Transcript_185827_2127).

SEQ ID NO: 15 discloses UGT76G1 isoform sequence for 807086 (Ref_Stevia_Transcript_185828_2195).

SEQ ID NO: 16 discloses UGT76G1 isoform sequence for 807086 (Ref_Stevia_Transcript_185829_807).

SEQ ID NO: 17 discloses UGT76G1 isoform sequence for 807086 (Ref_Stevia_Transcript_185830_799).

SEQ ID NO: 18 discloses UGT76G1 isoform sequence for 807086 (Ref_Stevia_Transcript_185831_875).

SEQ ID NO: 19 discloses UGT76G1 isoform sequence for 817096 (Ref_Stevia_Transcript_185827_2127).

SEQ ID NO: 20 discloses UGT76G1 isoform sequence for 817096 (Ref_Stevia_Transcript_185828_2195).

SEQ ID NO: 21 discloses UGT76G1 isoform sequence for 817096 (Ref_Stevia_Transcript_185829_807).

SEQ ID NO: 22 discloses UGT76G1 isoform sequence for 817096 (Ref_Stevia_Transcript_185830_799).

SEQ ID NO: 23 discloses UGT76G1 isoform sequence for 817096 (Ref_Stevia_Transcript_185831_875).

SEQ ID NO: 24 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203252_1370).

SEQ ID NO: 25 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203253_1205).

SEQ ID NO: 26 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203254_1266).

SEQ ID NO: 27 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203255_1292).

SEQ ID NO: 28 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203256_1213).

SEQ ID NO: 29 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203257_1280).

SEQ ID NO: 30 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203258_1288).

SEQ ID NO: 31 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203259_1283).

SEQ ID NO: 32 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203260_1379).

SEQ ID NO: 33 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203261_1197).

SEQ ID NO: 34 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203262_573).

SEQ ID NO: 35 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203263_1281).

SEQ ID NO: 36 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203264_1275).

SEQ ID NO: 37 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203265_1307).

SEQ ID NO: 38 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203266_1208).

SEQ ID NO: 39 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203267_1341).

SEQ ID NO: 40 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203268_1289).

SEQ ID NO: 41 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203269_1279).

SEQ ID NO: 42 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203270_1322).

SEQ ID NO: 43 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203271_674).

SEQ ID NO: 44 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203272_1360).

SEQ ID NO: 45 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203273_539).

SEQ ID NO: 46 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203274_1332).

SEQ ID NO: 47 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203275_1284).

SEQ ID NO: 48 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203276_1297).

SEQ ID NO: 49 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203277_1194).

SEQ ID NO: 50 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203278_575).

SEQ ID NO: 51 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203279_1232).

SEQ ID NO: 52 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203280_1310).

SEQ ID NO: 53 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203281_1316).

SEQ ID NO: 54 discloses UGT91D2 isoform sequence for 817096 (Ref_Stevia_Transcript_203282_1272).

SEQ ID NO: 55 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203252_1370).

SEQ ID NO: 56 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203253_1205).

SEQ ID NO: 57 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203254_1266).

SEQ ID NO: 58 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203255_1292).

SEQ ID NO: 59 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203256_1213).

SEQ ID NO: 60 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203257_1280).

SEQ ID NO: 61 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203258_1288).

SEQ ID NO: 62 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203259_1283).

SEQ ID NO: 63 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203260_1379).

SEQ ID NO: 64 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203261_1197).

SEQ ID NO: 65 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203262_573).

SEQ ID NO: 66 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203263_1281).

SEQ ID NO: 67 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203264_1275).

SEQ ID NO: 68 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203265_1307).

SEQ ID NO: 69 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203266_1208).

SEQ ID NO: 70 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203267_1341).

SEQ ID NO: 71 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203268_1289).

SEQ ID NO: 72 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203269_1279).

SEQ ID NO: 73 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203270_1322).

SEQ ID NO: 74 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203271_674).

SEQ ID NO: 75 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203272_1360).

SEQ ID NO: 76 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203273_539).

SEQ ID NO: 77 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203274_1332).

SEQ ID NO: 78 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203275_1284).

SEQ ID NO: 79 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203276_1297).

SEQ ID NO: 80 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203277_1194).

SEQ ID NO: 81 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203278_575).

SEQ ID NO: 82 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203279_1232).

SEQ ID NO: 83 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203280_1310).

SEQ ID NO: 84 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203281_1316).

SEQ ID NO: 85 discloses UGT91D2 isoform sequence for 807086 (Ref_Stevia_Transcript_203282_1272).

SEQ ID NO: 86 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203252_1370).

SEQ ID NO: 87 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203253_1205).

SEQ ID NO: 88 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203254_1266).

SEQ ID NO: 89 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203255_1292).

SEQ ID NO: 90 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203256_1213).

SEQ ID NO: 91 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203257_1280).

SEQ ID NO: 92 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203258_1288).

SEQ ID NO: 93 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203259_1283).

SEQ ID NO: 94 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203260_1379).

SEQ ID NO: 95 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203261_1197).

SEQ ID NO: 96 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203262_573).

SEQ ID NO: 97 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203263_1281).

SEQ ID NO: 98 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203264_1275).

SEQ ID NO: 99 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203265_1307).

SEQ ID NO: 100 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203266_1208).

SEQ ID NO: 101 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203267_1341).

SEQ ID NO: 102 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203268_1289).

SEQ ID NO: 103 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203269_1279).

SEQ ID NO: 104 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203270_1322).

SEQ ID NO: 105 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203271_674).

SEQ ID NO: 106 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203272_1360).

SEQ ID NO: 107 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203273_539).

SEQ ID NO: 108 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203274_1332).

SEQ ID NO: 109 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203275_1284).

SEQ ID NO: 110 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203276_1297).

SEQ ID NO: 111 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203277_1194).

SEQ ID NO: 112 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203278_575).

SEQ ID NO: 113 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203279_1232).

SEQ ID NO: 114 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203280_1310).

SEQ ID NO: 115 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203281_1316).

SEQ ID NO: 116 discloses UGT91D2 isoform sequence for 814011 (Ref_Stevia_Transcript_203282_1272).

SEQ ID NO: 117 discloses the forward primer for SNP2.

SEQ ID NO: 118 discloses the reverse primer for SNP2.

SEQ ID NO: 119 discloses the forward primer for SNP10.

SEQ ID NO: 120 discloses the reverse primer for SNP10.

SEQ ID NO: 121 discloses the forward primer for SNP12.

SEQ ID NO: 122 discloses the reverse primer for SNP12.

SEQ ID NO: 123 discloses the forward primer for SNP17.

SEQ ID NO: 124 discloses the reverse primer for SNP17.

SEQ ID NO: 125 discloses the forward primer for SNP19.

SEQ ID NO: 126 discloses the reverse primer for SNP19.

SEQ ID NO: 127 discloses the forward primer for SNP20.

SEQ ID NO: 128 discloses the reverse primer for SNP20.

SEQ ID NO: 129 discloses the forward primer for SNP22.

SEQ ID NO: 130 discloses the reverse primer for SNP22.

SEQ ID NO: 131 discloses the forward primer for SNP24.

SEQ ID NO: 132 discloses the reverse primer for SNP24.

SEQ ID NO: 133 discloses the forward primer for the SNP17 probe.

SEQ ID NO: 134 discloses the reverse primer for the SNP17 probe.

SEQ ID NO: 135 discloses the forward primer for the SNP19 probe.

SEQ ID NO: 136 discloses the reverse primer for the SNP19 probe.

SEQ ID NO: 137 discloses the forward primer for the SNP20 probe.

SEQ ID NO: 138 discloses the reverse primer for the SNP20 probe.

BRIEF DESCRIPTION OF THE FIGURES

The accompanying figures, which are incorporated herein and form a part of the specification, illustrate some, but not the only or exclusive, example embodiments and/or features. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than limiting.

FIG. 1 shows a flow diagram showing the stage involved for the identification of putative SNPs markers.

FIG. 2 shows a flow diagram showing the stage involved for these 48 putative SNPs markers verification across 30 stevia plants with contrasting steviol glycoside composition.

FIG. 3 shows PCR amplification of SNP2 as well as the location of the substitution of a G nucleotide to a C.

FIG. 4 shows PCR amplification of SNP10 as well as the location of the substitution of a G nucleotide to an A.

FIG. 5 shows PCR amplification of SNP12 as well as the location of the substitution of an C nucleotide to a T.

FIG. 6 shows PCR amplification of SNP17 as well as the location of the substitution of an A nucleotide to a C.

FIG. 7 shows PCR amplification of SNP19 as well as the location of the substitution of an A nucleotide to a T.

FIG. 8 shows PCR amplification of SNP20 as well as the location of the substitution of a G nucleotide to an A.

FIG. 9 shows PCR amplification of SNP22 as well as the location of the substitution of a T nucleotide to a G.

FIG. 10 shows PCR amplification of SNP24 as well as the location of the substitution of a G nucleotide to an A.

FIG. 11 shows the breeding scheme for variety ‘814011’. ‘814011’ originated from a tri-cross conducted in Ganzhou, Jiangxi Province, the People's Republic of China in September 2013 between the proprietary male Stevia variety ‘YF001’ (unpatented) and an F₁ derived from a cross between the female Stevia variety ‘Eirete’ (unpatented) and the proprietary male Stevia variety ‘AKHL1’ (U.S. Plant Patent No. 23,164) and the proprietary female variety ‘PC Star 2’ (unpatented).

FIG. 12 shows the breeding scheme for variety ‘807086’. ‘807086’ is a selection that results from a tri-cross conducted in Ganzhou, Jiangxi Province, the People's Republic of China of the proprietary F₁ male stevia line ‘YF003’ (unpatented) (from the cross of the female parent ‘AKH EM1’(unpatented) and the male parent ‘AKH L4’ (US Plant Patent 23,728)) and the female stevia line ‘PC Star 2’ (unpatented).

FIG. 13 shows the breeding scheme for varieties ‘817096’, ‘801094’, ‘804038’, ‘801105’, ‘816055’, ‘804075’, ‘830098’, ‘806058’, ‘810103’, ‘803071’, ‘805061’, ‘813081’, ‘806034’ and ‘803065’. These varieties resulted from a backcross conducted in Ganzhou, Jiangxi Province, the People's Republic of China. The proprietary F₁ male stevia line ‘YF002’ (unpatented) (derived from a cross between female parent ‘AKH/G.8.D’ (unpatented) and male parent ‘AKH L1’ (U.S. Plant Patent No. 23,164)) was backcrossed to female parent ‘AKH/G.8.D’.

FIG. 14 discloses a multiple sequence alignment of various UGT76G1 isoforms from 814011 plants. (1=Ref_Stevia_Transcript_185827_2127), (2=Ref_Stevia_Transcript_185828_2195), (3=Ref_Stevia_Transcript_185829_807), (4=Ref_Stevia_Transcript_185830_799) and (5=Ref_Stevia_Transcript_185831_875).

FIG. 15 discloses a multiple sequence alignment of various UGT76G1 Ref_Stevia_Transcript_185827_2127 isoforms across (9)=814011, (14)=807086 and (19)=817096. All these isoforms shared 99% nucleotide identity with few SNPs.

FIG. 16 discloses a multiple sequence alignment of various UGT76G1 Ref_Stevia_Transcript_185828_2195 isoforms across (10)=814011, (15)=807086 and (20)=817096. All these isoforms shared 99% nucleotide identity with few SNPs.

FIG. 17 discloses a multiple sequence alignment of various UGT76G1 Ref_Stevia_Transcript_185829_807 isoforms across (1)=814011, (2)=807086 and (3)=817096. All these isoforms shared 99% nucleotide identity with few SNPs.

FIG. 18 discloses a multiple sequence alignment of various UGT76G1 Ref_Stevia_Transcript_185830_799 isoforms across (1)=814011, (2)=807086 and (3)=817096. All these isoforms shared 99% nucleotide identity with few SNPs.

FIG. 19 discloses a multiple sequence alignment of various UGT76G1 Ref_Stevia_Transcript_185831_875 isoforms across (1)=814011, (2)=807086 and (3)=817096. All these isoforms shared 99% nucleotide identity with few SNPs.

FIG. 20 discloses a multiple sequence alignment of various UGT91D2 isoforms from 817096. (1=>Ref_Stevia_Transcript_203252_1370), (2=>Ref_Stevia_Transcript_203253_1205), (3=>Ref_Stevia_Transcript_203254_1266), (4=>Ref_Stevia_Transcript_203255_1292), (5=>Ref_Stevia_Transcript_203256_1213), (6=>Ref_Stevia_Transcript_203257_1280), (7=>Ref_Stevia_Transcript_203258_1288), (8=>Ref_Stevia_Transcript_203259_1283), (9=>Ref_Stevia_Transcript_203260_1379), (10=>Ref_Stevia_Transcript_203261_1197), (11=>Ref_Stevia_Transcript_203262_573), (12=>Ref_Stevia_Transcript_203263_1281), (13=>Ref_Stevia_Transcript_203264_1275), (14=>Ref_Stevia_Transcript_203265_1307), (15=>Ref_Stevia_Transcript_203266_1208), (16=>Ref_Stevia_Transcript_203267_1341), (17=>Ref_Stevia_Transcript_203268_1289), (18=>Ref_Stevia_Transcript_203269_1279), (19=>Ref_Stevia_Transcript_203270_1322), (20=>Ref_Stevia_Transcript_203271_674), (21=>Ref_Stevia_Transcript_203272_1360), (22=>Ref_Stevia_Transcript_203273_539), (23=>Ref_Stevia_Transcript_203274_1332), (24=>Ref_Stevia_Transcript_203275_1284), (25=>Ref_Stevia_Transcript_203276_1297), (26=>Ref_Stevia_Transcript_203277_1194), (27=>Ref_Stevia_Transcript_203278_575), (28=>Ref_Stevia_Transcript_203279_1232), (29=>Ref_Stevia_Transcript_203280_1310), (30=>Ref_Stevia_Transcript_203281_1316), (31=>Ref_Stevia_Transcript_203282_1272).

FIG. 21 discloses a multiple sequence alignment of various UGT91D2>Ref_Stevia_Transcript_203252_1370 isoforms across 814011, 807086 and 817096. All these isoforms shared 99% nucleotide identity with few SNPs.

DEFINITIONS

In the description and tables, which follow, a number of terms are used. In order to provide a clear and consistent understanding of the specification and claims, including the scope to be given such terms, the following definitions are provided. All rebaudioside contents are represented as a percentage of the dry weight of leaves.

High rebaudioside A: As used herein, plants described as having high rebaudioside A have a rebaudioside A content of greater than or equal to 9%, a rebaudioside D content of less than or equal to 0.3%, and a rebaudioside M content of less than or equal to 0.2%.

High rebaudioside D: As used herein, plants described as having high rebaudioside D have a rebaudioside D content of greater than or equal to 0.6% and a rebaudioside D/total steviol glycoside greater than or equal to 8%.

High rebaudioside D and high rebaudioside M: As used herein, plants described as having rebaudioside D and high rebaudioside M content have a rebaudioside D content of greater than or equal to 0.6% and a rebaudioside D/total steviol glycoside greater than or equal to 8%, and a rebaudioside M content that is greater than or equal to 0.5%.

High rebaudioside M: As used herein, plants described as having high rebaudioside M have a rebaudioside M content that is greater than or equal to 0.5%.

High stevioside: As used herein, plants described as having high stevioside have a stevioside content of greater than or equal to 7%, a rebaudioside D content of less than or equal to 0.3%, and a rebaudioside M content of less than or equal to 0.2%.

High stevioside and high rebaudioside A: As used herein, plants described as having high stevioside and high rebaudioside A have a rebaudioside D/total steviol glycoside less than or equal to 7.60% and a rebaudioside M/total steviol glycoside less than or equal to 1.9%.

Marker: As used herein, a “marker” is an indicator for the presence of at least one polymorphism, thus a marker can be the nucleotide sequence itself, or a probe, for example.

Plant: As used herein, the term “plant” includes reference to an immature or mature whole plant, including a plant that has been processed for steviol glycosides. Seed or plant part that will produce the plant is also considered to be the plant.

Plant Part: As used herein, the term “plant part” includes leaves, stems, roots, seed, embryo, pollen, ovules, flowers, root tips, anthers, tissue, cells and the like.

Rebaudioside A (RebA): As used herein “Rebaudioside A” or “RebA” is a steviol glycoside that contains only glucose as its monosaccharide moieties. It contains four glucose molecules in total with the central glucose of the triplet connected to the main steviol structure at its hydroxyl group, and the remaining glucose at its carboxyl group forming an ester bond.

Rebaudioside D (RebD): As used herein, “Rebaudioside D” or “RebD” is an ent-kaurane diterpene glycoside isolated from Stevia rebaudiana.

Rebaudioside M (RebM): As used herein, “Rebaudioside M” or “RebM” is an ent-kaurane diterpene glycoside isolated from Stevia rebaudiana.

SNP: As used herein, the term “SNP” shall refer to a single nucleotide polymorphism.

Stevioside content: As used herein, stevioside is the percent glycoside derived from the stevia plant.

DETAILED DESCRIPTION OF THE INVENTION

Embodiments described herein provide stevia plants containing eight (8) SNP markers in homozygous form, SNP2, SNP12, SNP17, SNP19, SNP20, SNP22, and SNP24. As will be described in detail below, stevia plants containing these eight SNPs are shown to express either high RebD, or high RebM or plants with all eight SNPs may express both high RebD and high RebM. Embodiments described herein also provide methods for screening for stevia plants containing these eight SNPs as well as methods and steps for using these SNPs in marker assisted breeding to produce stevia plants expressing either high RebD, or RebM or plants with all eight SNPs may express both high RebD and high RebM. Also described herein are methods for introgressing all eight SNPs associated with high RebD and high RebM into stevia plants by selecting plants comprising for one or more SNPs and breeding with such plants to confer such desirable agronomic phenotypes to plant progeny.

Stevia rebaudiana (Bertoni) is a herbaceous perennial plant of family Asteraceae, which consists of approximately 230 species of herbaceous, shrub and sub-shrub plants. Stevia rebaudiana is known to yield diterpenoid steviol glycosides (SGs), which are about 300 times sweeter than sucrose. Twenty-one diterpene glycosides have been identified in leaf tissues of stevia (US2011/0183056). Among these, four major steviol glycosides synthesized in the leaves of stevia are stevioside (STEV), RebA, rebaudioside C (RebC) and rebaudioside F (RebF). STEV account for 5-10% of the dry weight of the leaves while RebA accounts for 2-4% (Pande and Priyanka 2013).

All Stevia rebaudiana planted across the whole world are 97-99% genetically identical with estimation of a 2GB genome. Genetic differences comprise only 2-3% of this 2GB genome among different Stevia rebaudiana plants and are the key attributes for stevia adaptability, growth performance, leaves sizes, disease resistance, variation in steviol glycosides composition and so on.

The present disclosure relates generally to stevia varieties, and more particularly to SNP markers and UGT isoforms for stevia varieties with high content of RebD and Rebaudioside M.

Although pathway enzymes of SG biosynthesis have been documented, there are still many uncertainties on the regulatory network involved in this SG biosynthesis. Through successive selection and crossing, new varieties of Stevia rebaudiana having very low RebD and RebM were produced. After several cycles of selection and intercrossing of superior parents, new varieties, ‘817096’, ‘814011’ and ‘807086’ with a higher amount of specific Reb D and RebM glycosides were obtained.

Discovery of SNPs markers for high RebD and RebM identification

As outlined in the flow diagram of FIG. 1, the present disclosure provides eight markers (the SNPs identified in SEQ ID NOs: 1-8) for the identification of stevia varieties with high RebD content, high RebM content or varieties with both RebD and RebM content. Methods for breeding and selection of new stevia varieties with high RebD and RebM contents are also described in further detail below. Briefly, as shown in step 102, through successive selection and crossing, new varieties of Stevia rebaudiana have been produced. In step 104, ten stevia leaf samples with contrasting glycosides composition (three high Stevioside (‘805028’, ‘803066’, and ‘805003’), three high RebA (‘817075’, ‘805126’, and ‘805082’), two high RebD (‘801094’ and ‘817096’) and two high RebM (‘814011’ and ‘807086’) (104) were studied for their genetic background. The two high RebD lines were produced using the breeding flow diagram shown in FIG. 13, while the two high RebM lines were produced using the breeding flow diagrams shown in FIGS. 11 and 12. Briefly, as shown in FIG. 11, parental varieties ‘Eirete’ and ‘AKHL1’ were crossed to produce ‘YF001’. This selection was outcrossed to ‘PC Star 2’ to produce high RebM line ‘814011’. As shown in FIG. 12, parental varieties ‘AKH EM1’ and ‘AKHL4’ were crossed to produce ‘YF003’. This selection was outcrossed to ‘PC Star 2’ to produce high RebM line ‘807086’. As shown in FIG. 13, parental varieties ‘AKH/G.8.D’ and ‘AKH L1’ were crossed to produce ‘YF002’. This selection was backcrossed to parental line ‘AKH/G.8.D’ to produce 14 high RebD lines, including ‘817096’ and ‘801094’.

As shown in step 106 of FIG. 1, varieties reported to have high Stevioside and high rebaudioside A were randomly selected. Genome sequencing was employed in each of these varieties for an approximate target coverage of 10× each. Genomic DNAs were isolated from the leaves of each of these varieties/lines using Nucleospin Plant II kit (Macherey-Nagel) following manufacturer's protocol. Extracted DNA quality and quantity were measured using NanoDrop 2000 (Thermo Fisher Scientific Inc., USA) and Qubit 2.0 DNA Broad Range Assay (Invitrogen, USA). The samples were also run on 1% agarose gel to determine the integrity of genomic DNA. At least 1 μg of high quality DNA (as measured by Qubit) is required for TruSeq library preparation. The isolated genomic DNA samples were fragmented using Covaris S220 (Covaris Inc, USA) to a targeted size of 400-700 bp. The fragmented DNA was then end end-repaired, ligated to Illumina TruSeq adapters, and PCR enriched using TruSeq DNA Sample Preparation kit (Illumina, USA) according to manufacturer's protocol. The final sequencing libraries were quantified using KAPA kit (KAPA Biosystem, USA) on Agilent Strategene Mx-3005p quantitative PCR (Agilent, USA) and library size was confirmed using Agilent Bioanalyzer High Sensitivity DNA Chips (Agilent, USA). The resulting libraries were sequenced using an Illumina flow cell with 202 cycles of the Illumina HiSeq2000 platform (Illumina, USA). The sequencing run generated a total of 235.4 GB of raw data.

In step 108 of FIG. 1, all ten stevia genomes from the ten stevia plants were assembled separately using the “MGRC Assembler Pipeline” software (version 1.4). A pan genome pooled assembly methodology was also performed using in-house assembly pipeline tools. The merged sequence yielded a draft genome assembly of 1.02 Gbp. There was a total of 269,395 contigs with minimum contig size of 1 kbp.

In step 110, SNPs were identified using Samtools from individual sample reads mapping against a database of the draft genome assembly. Approximately 7.8 million SNPs were identified across the ten genomes. In step 112, of these 7.8 million SNPs, only 48 SNPs were putative SNPs for RebD and RebM identification. NCBI (National Centre of Biotechnological Information) BLAST® analysis indicated that these SNPs had not been reported in a public database.

The flow diagram of FIG. 2 outlines how the eight SNPs for high RebD and high RebM were identified. Briefly, following additional breeding (shown in step 202), in step 204 leaf samples with contrasting glycoside composition were analyzed via HPLC (High Performance Liquid Chromatography). SNP primers were designed in step 206 and DNA was extracted in step 208 for PCR amplification of the SNP region (shown in step 210). In step 212, PCR products were sequenced to determine alleles. In step, 214, eight SNPs for high RebD and high RebM were identified.

As shown in the flow diagram of FIG. 2, a total of 30 leaf samples with contrasting glycosides composition (9 high rebaudioside A, 5 high Stevioside, 14 high RebD and 2 high RebM) were selected for HPLC verification of the 48 putative SNP markers (204). Stevia varieties reported to have high Stevioside or high rebaudioside A were randomly selected. The 14 high RebD lines were produced using the breeding flow diagram shown in FIG. 13, while the two high RebM lines were produced using the breeding flow diagrams shown in FIGS. 11 and 12. Table 1 below shows the HPLC data of these 30 lines selected for SNP verification.

For HPLC analysis, the stevia leaf samples were air-dried/oven-dried before grinding into fine powder using a pestle and mortar. For each sample, leaf powder (100 mg) was extracted with 15 ml of 60° C. distilled water for 18 hours. The mixture was centrifuged and the supernatant filtered and collected for steviol glycoside composition analysis by HPLC (Agilent, USA). The analysis of steviol glycosides was carried out using an Agilent Technologies 1200 Series (USA) HPLC equipped Agilent Poroshell 120 SB-C18 2.7 μm, 4.6×150 mm. A diode array set at 210 nm was used as the detector. The reference standards for all glycosides, including rebaudioside E, RebD, RebM, rebaudioside N, and rebaudioside O were purchased from ChromaDex Inc. (USA). The following method was used for analysis of Rebaudioside E (RebE), RebD, RebM, Rebaudioside N (RebN), and Rebaudioside O (RebO): column temperature: 40° C., mobile phase: Solvent A 10 mM Monosodium dihydrogen Phosphate pH2.6: Acetonitrile, 75%:25% (v/v), Solvent B Water: Acetonitrile, 50%:50% (v/v), Gradient program % v/v: at 0.0 and 14.0 minutes 100% A and 0% B, at 14.5 and 25.0 minutes 100% B and 0% A, flow rate: 0.5 mL/min, injection: 5 μL, autosampler temperature: ambient. To analyze Rebaudioside A (RebA), Stevioside (Stev), Rebaudioside F (RebF), Rebaudioside C (RebC), Dulcoside A (DulA), Rubusoside (Rub), Rebaudioside B (RebB), and Steviolbioside (Stev) the same method as described above was used except the mobile phase consisted of Isocratic 10 mM Monosodium dihydrogen Phosphate pH 2.6: Acetonitrile, 68%:32% (v/v) at a flow rate of 1.0 mL/min, with a run time of 20 minutes. 13 compounds, RebA, RebD, RebM, Rebaudioside E, Stevioside, Rebaudioside N, Rebaudioside O, Rebaudioside F, Rebaudioside C, Dulcoside A, Rubusoside, Rebaudioside B, and Steviolbioside were identified.

Table 1 provides an analysis of steviol glycosides in 30 stevia varieties. The top row of Table 1 shows the various glycosides group, and the first column shows the stevia variety and the classification as a high RebD, high RebM, high RebD/RebM, high RebA, high Stev or high RebA/Stev line. The numbers in Table 1 represent the percentage of a particular rebaudioside group in a specific stevia variety. High RebD lines are defined as having a RebD content that is ≥0.6% and a RD/TSG≥8%. High RebM lines are defined as having a RebM content that is ≥0.5%. High RebA lines are defined as having a RebA content that is ≥9%, a RebD content that is ≤0.3%, and a RebM content of ≤0.2%. High Stev lines are defined as having a Stev content of ≥7%, a RebD content of ≤0.3%, and a, RebM content of ≤0.2%. TSG=total steviol glycoside. Deposited varieties ‘817096’, ‘814011’, and ‘807086’ are bolded.

Table 2 shows a descriptive statistical analysis of the first 16 varieties shown in Table 1, all designated as high RebD. The last two varieties of this group, ‘814011’ and ‘807086’ are also designated as high RebM. Min=minimum, Max=maximum, SV=sample variance, SD=standard deviation, SD=standard error.

TABLE 1 HPLC analysis of steviol glycosides in 30 stevia varieties Variety/ Sample ID DA Stev RebC RebF RebA RebD RebM TSG RA/TSG ST/TSG RD/TSG RM/TSG 804038 0.00 0.66 0.35 0.05 3.42 2.23 0.48 7.19 47.57 9.18 31.02 6.68 (RebD) 801105 0.00 0.33 0.55 0.16 7.13 1.14 0.38 9.69 73.58 3.41 11.76 3.92 (RebD) 816055 0.01 0.26 0.47 0.21 6.94 0.89 0.31 9.09 76.35 2.86 9.79 3.41 (RebD) 817096 0.05 2.06 0.50 0.10 2.35 3.28 0.38 8.72 26.95 23.62 37.61 4.36 (RebD) 801094 0.00 0.63 0.62 0.09 5.41 1.62 0.25 8.62 62.76 7.31 18.79 2.90 (RebD) 804075 0.00 0.57 0.41 0.16 4.35 0.97 0.24 6.70 64.93 8.51 14.48 3.58 (RebD) 806058 0.02 0.42 0.38 0.13 5.32 0.83 0.00 7.10 74.93 5.92 11.69 0 (Reb D) 810103 0.00 0.28 0.46 0.15 4.52 0.95 0.00 6.36 71.07 4.40 14.94 0 (Reb D) 803071 0.00 0.44 0.48 0.11 4.30 0.70 0.00 6.03 71.31 7.30 11.61 0 (RebD) 805061 0.02 0.42 0.09 0.04 4.32 1.07 0.00 5.96 72.48 7.05 17.95 0 (RebD) 813081 0.01 0.30 0.31 0.11 4.54 0.65 0.00 5.92 76.69 5.07 10.98 0 (RebD) 806034 0.00 0.21 0.25 0.09 3.71 0.62 0.00 4.88 76.02 4.30 12.70 0 (RebD) 830098 0.00 0.41 0.53 0.12 5.51 1.03 0.00 7.60 72.50 5.39 13.55 0 (RebD) 803065 0.00 0.72 0.42 0.10 4.13 0.63 0.00 6.00 68.83 12 10.50 0 (RebD) 814011 0.02 0.38 0.76 0.21 8.45 1.11 1.12 12.05 70.12 3.15 9.21 9.29 (RebD/ RebM) 807086 0.00 0.21 0.32 0.08 4.15 1.55 1.00 7.31 56.77 2.87 21.20 13.68 (RebD/ RebM) 805082 0.00 0.65 0.54 0.07 10.78 0.18 0.00 12.22 88.22 5.32 1.47 0 (RebA) 817075 0.00 0.56 0.51 0.08 10.68 0.19 0.00 12.02 88.85 4.66 1.58 0 (RebA) 805126 0.00 0.45 0.63 0.07 10.77 0.25 0.00 12.17 88.50 3.70 2.05 0 (RebA) 815034 0.00 0.69 0.77 0.25 9.51 0.20 0.00 11.42 83.27 6.04 1.75 0 (RebA) 802057 0.00 0.56 1.06 0.32 11.55 0.17 0.00 13.66 84.55 4.10 1.24 0 (RebA) 812051 0.01 0.56 0.91 0.28 11.44 0.17 0.00 13.37 85.56 4.19 1.27 0 (RebA) 805068 0.00 1.09 0.83 0.06 12.32 0.10 0.00 14.40 85.56 7.57 0.69 0 (RebA) 813057 0.00 0.54 0.99 0.21 12.29 0.15 0.00 14.18 86.67 3.81 1.06 0 (RebA) 805000 1.05 10.13 0.01 0.01 0.1 0.04 0.00 11.34 0.88 89.33 0.35 0 3 (Stev) 805028 0.81 9.58 0.02 0.01 0.18 0.02 0.00 10.62 1.69 90.21 0.19 0 (Stev) 803066 0.93 10.03 0.03 0.02 0.26 0.01 0.00 11.28 2.30 88.92 0.09 0 (Stev) 412-31 0.44 8.57 0.02 0.00 0.13 0.08 0.00 9.24 1.41 92.75 0.87 0 (Stev) 43-2 0.53 7.87 0.12 0.01 0.28 0.00 0.00 8.81 3.18 89.33 0.00 0 (Stev) 49-58 0.05 11.36 0.02 0.00 0.43 0.02 0.00 11.88 3.62 95.62 0.17 0 (Stev)

TABLE 2 Analysis of steviol glycosides in lines designated as high RebD shown in Table 1 Min Max Range SV SD SE Mean DA 0 0.05 0.05 0 0.01 0 0 Stev 0.21 2.06 1.85 0.19 0.44 0.11 0.52 RebC 0.09 0.76 0.67 0.02 0.16 0.04 0.43 RebF 0.04 0.21 0.17 0 0.05 0.01 0.12 RebA 2.35 8.45 6.1 2.34 1.53 0.38 4.91 RebD 0.62 3.28 2.66 0.49 0.70 0.17 1.20 RebM 0 1.12 1.12 0.13 0.36 0.09 0.26 TSG 4.88 12.05 7.17 3.27 1.81 0.45 7.45 RA/TSG 26.95 76.69 49.74 172.04 13.12 3.28 66.43 ST/TSG 2.86 23.62 20.76 26.13 5.11 1.28 7.02 RD/TSG 9.21 37.61 28.4 63.15 7.95 1.99 16.11 RM/TSG 0 13.68 13.68 16.16 4.02 1.00 2.99

As shown in Table 1 and Table 2 above, the 16 stevia varieties classified as high RebD had a RebD content that ranged between approximately 0.6% and 3.3% and a RD/TSG that ranged between approximately 9.2% and 38% (see Table 2). Within these 16 varieties, two were classified as also having high RebM (see Table 1, varieties labeled ‘814011’ and ‘807086’ in bold font). The RebM content ranged between approximately 0% and 1.15% and the RM/TSG ranged between approximately 0% and 14%. Other varieties having even higher contents of RebD, RebM, or RebD and RebM and SEQ ID NOs: 1-8 are contemplated by this invention.

As further outlined in the flow diagram of FIG. 2, primers were designed for each of the 48 putative SNP markers (shown in step 206) and were used for SNP amplification of extracted DNA (shown in step 208). The 48 SNPs markers identified from the SNPs discovery stage (FIG. 1) were selected for further verification using SNP gene amplification across the randomly selected 30 stevia plants with contrasting steviol glycoside composition (see Table 1). These 30 plants were obtained through three different parental groups of crossing (FIGS. 11, 12, and 13) and hence, contain the best genetic materials for putative SNPs verification. A total of 48 pairs of SNPs primers were designed using primer 3 software and synthesized by Integrated DNA Technologies (IDT; Coralville, Iowa).

DNA was extracted (step 208) from the frozen leaves of 30 different stevia plants with contrasting glycosides composition (see Table 1) using DNeasy Plant Mini kit (Qiagen, Germany) or Nucleospin Plant II kit (Macherey-Nagel). Extracted DNA quantity were measured using Fluorescence dsDNA Assay and quality were analyzed using agarose gel 1% (75 Volt, 60 minutes). Good quality DNA with a concentration around 10 ng was selected for PCR amplification using each SNP primer set (step 210).

PCR (step 210) was performed using the following 34 cycle protocol: an initial three minute denaturation at 94° C., with subsequent cycles having a denaturation of 30 seconds at 94° C.; annealing at 55° C. for 30 seconds; and an extension at 72° C. for one minute, with a final extension of ten minutes.

The PCR products obtained were run on 1.5% agarose gel (60 min, 75 volt) to check the specificity of the amplified products. The amplification products were purified and sequenced with an automatic ABI 3730 sequencer. SNP locations were analyzed across these 30 samples using Sequence Scanner v1.0 (Applied Biosystems) software (step 212) and sequencing verification indicated only eight SNPs (SNP2, SNP10, SNP12, SNP17, SNP19, SNP20, SNP22 & SNP24) are real SNP markers for high RebD and RebM identification (step 214). The PCR primers and product length in base pairs (bp) for each of the eight SNPs, as well as their location, is shown in Table 3.

TABLE 3 SNP locus and primers Forward Reverse Product Length (bp) SNP primer primer and SEQ ID NO SNP location SNP2 SEQ ID SEQ ID 481 bp G to C at 225 No: 117 No: 118 SEQ ID NO: 1 SNP10 SEQ ID SEQ ID 359 bp G to A at 187 No: 119 No: 120 SEQ ID NO: 2 SNP12 SEQ ID SEQ ID 681 bp C to T at 345 No: 121 No: 122 SEQ ID NO: 3 SNP17 SEQ ID SEQ ID 285 bp A to C at 129 No: 123 No: 124 SEQ ID NO: 4 SNP19 SEQ ID SEQ ID 396 bp A to T at 173 No: 125 No: 126 SEQ ID NO: 5 SNP20 SEQ ID SEQ ID 500 bp G to A at 221 No: 127 No: 128 SEQ ID NO: 6 SNP22 SEQ ID SEQ ID 486 bp T to G at 160 No: 129 No: 130 SEQ ID NO: 7 SNP24 SEQ ID SEQ ID 500 bp G to A at 325 No: 131 No: 132 SEQ ID NO: 8

As shown in FIG. 3, the genomic region containing SNP2 (SEQ ID NO:1) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 481 base pair length bands on the gel electrophoresis image, and the G to C SNP at base pair location 225 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 3, any stevia plants with high Stev and high RebA can be either homozygous dominant GG alleles or heterozygous GC alleles. Allele G is dominant to allele C and allele C is recessive to allele G. Any stevia plants with this homozygous dominant GG allele combination are stable for high Stev and RebA variety. Since allele G is dominant to allele C, any individuals with GC genotype can be of high Stev or high RebA variety as the dominant allele G masks the effect of recessive allele C. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive CC alleles (corresponding to SNP2). Any progeny with this CC genotype will be identified as high RebD and RebM lines.

As shown in FIG. 4, the genomic region containing SNP10 (SEQ ID NO:2) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 359 base pair length bands on the gel electrophoresis image, and the G to A SNP at base pair location 187 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 4, any stevia plants with high Stev and high RebA can be either homozygous dominant GG alleles or heterozygous AG alleles. Allele G is dominant to allele A and allele A is recessive to allele G. Any stevia plants with this homozygous dominant GG allele combination are stable for high Stev and RebA variety. Since allele G is dominant to allele A, any individuals with AG genotype can be of high Stev or high RebA variety as the dominant allele G masks the effect of recessive allele A. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive AA alleles (corresponding to SNP10). Any progeny with this AA genotype will be identified as high RebD and RebM lines.

As shown in FIG. 5, the genomic region containing SNP12 (SEQ ID NO:3) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 681 base pair length bands on the gel electrophoresis image, and the C to T SNP at base pair location 345 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 5, any stevia plants with high Stev and high RebA can be either homozygous dominant CC alleles or heterozygous CT alleles. Allele C is dominant to allele T and allele T is recessive to allele C. Any stevia plants with this homozygous dominant CC allele combination are stable for high Stev and RebA variety. Since allele C is dominant to allele T, any individuals with CT genotype can be of high Stev or high RebA variety as the dominant allele C masks the effect of recessive allele T. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive TT alleles (corresponding to SNP12). Any progeny with this TT genotype will be identified as high RebD and RebM lines.

As shown in FIG. 6, the genomic region containing SNP17 (SEQ ID NO:4) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 285 base pair length bands on the gel electrophoresis image, and the A to C SNP at base pair location 129 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 6, any stevia plants with high Stev and high RebA can be either homozygous dominant AA alleles or heterozygous AC alleles. Allele A is dominant to allele C and allele C is recessive to allele A. Any stevia plants with this homozygous dominant AA allele combination are stable for high Stev and RebA variety. Since allele A is dominant to allele C, any individuals with AC genotype can be of high Stev or high RebA variety as the dominant allele A masks the effect of recessive allele C. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive CC alleles (corresponding to SNP17). Any progeny with this CC genotype will be identified as high RebD and RebM lines.

As shown in FIG. 7, the genomic region containing SNP19 (SEQ ID NO:5) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 396 base pair length bands on the gel electrophoresis image, and the A to T SNP at base pair location 173 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 7, any stevia plants with high Stev and high RebA can be either homozygous dominant AA alleles or heterozygous AT alleles. Allele A is dominant to allele T and allele T is recessive to allele A. Any stevia plants with this homozygous dominant AA allele combination are stable for high Stev and RebA variety. Since allele A is dominant to allele T, any individuals with AT genotype can be of high Stev or high RebA variety as the dominant allele A masks the effect of recessive allele T. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive TT alleles (corresponding to SNP19). Any progeny with this TT genotype will be identified as high RebD and RebM lines.

As shown in FIG. 8, the genomic region containing SNP20 (SEQ ID NO:6) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 500 base pair length bands on the gel electrophoresis image, and the G to A SNP at base pair location 221 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 8, any stevia plants with high Stev and high RebA can be either homozygous dominant GG alleles or heterozygous GA alleles. Allele G is dominant to allele A and allele A is recessive to allele G. Any stevia plants with this homozygous dominant GG allele combination are stable for high Stev and RebA variety. Since allele G is dominant to allele A, any individuals with GA genotype can be of high Stev or high RebA variety as the dominant allele G masks the effect of recessive allele A. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive AA alleles (corresponding to SNP20). Any progeny with this AA genotype will be identified as high RebD and RebM lines.

As shown in FIG. 9, the genomic region containing SNP22 (SEQ ID NO:7) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 486 base pair length bands on the gel electrophoresis image, and the T to G SNP at base pair location 160 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 9, any stevia plants with high Stev and high RebA can be either homozygous dominant TT alleles or heterozygous TG alleles. Allele T is dominant to allele G and allele G is recessive to allele T. Any stevia plants with this homozygous dominant TT allele combination are stable for high Stev and RebA variety. Since allele T is dominant to allele G, any individuals with TG genotype can be of high Stev or high RebA variety as the dominant allele T masks the effect of recessive allele G. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive GG alleles (corresponding to SNP22). Any progeny with this GG genotype will be identified as high RebD and RebM lines.

As shown in FIG. 10, the genomic region containing SNP24 (SEQ ID NO:8) has been amplified using the primer sequences referenced above in Table 3. The PCR product is shown as 500 base pair length bands on the gel electrophoresis image, and the G to A SNP at base pair location 325 is underlined in the sequence below the gel image.

As shown in the data of Table 4 and in FIG. 10, any stevia plants with high Stev and high RebA can be either homozygous dominant GG alleles or heterozygous GA alleles. Allele G is dominant to allele A and allele A is recessive to allele G. Any stevia plants with this homozygous dominant GG allele combination are stable for high Stev and RebA variety. Since allele G is dominant to allele A, any individuals with GA genotype can be of high Stev or high RebA variety as the dominant allele G masks the effect of recessive allele A. Allele assortment among those high Stev and high RebA varieties or progeny after several generations results in the generation of progeny with recessive AA alleles (corresponding to SNP24). Any progeny with this AA genotype will be identified as high RebD and RebM lines.

As shown in FIGS. 3 through 10, and summarized below in Table 4, stevia varieties with high content of RebD and RebM have SNP2 (CC genotype), SNP10 (AA genotype), SNP12 (TT genotype), SNP17 (CC genotype), SNP19 (TT genotype), SNP20 (AA genotype), SNP22 (GG genotype), and SNP24 (AA genotype).

TABLE 4 SNP markers and genotypes Samples identification using Sanger Sequencer (first generation) and Illumina SNPs HiSeq 2000 Sequencer (second generation) markers RebD, RebM lines Stevioside, RebA lines SNP2 CC genotype GG or GC genotype SNP10 AA genotype GG or GA genotype SNP12 TT genotype CC or CT genotype SNP17 CC genotype AA or AC genotype SNP19 TT genotype AA or AT genotype SNP20 AA genotype GG or AG genotype SNP22 GG genotype TT or TG genotype SNP24 AA genotype GG or GA genotype

One embodiment of the instant application discloses a stevia plant comprising the following single nucleotide polymorphisms (SNPs), wherein said SNPs are found in homozygous form: SNP2, which comprises a G to C nucleotide substitution at position number 225 in SEQ ID NO:1, SNP10, which comprises a G to A nucleotide substitution at position number 187 in SEQ ID NO:2, SNP12, which comprises an C to T nucleotide exchange at position number 345 in SEQ ID NO:3, SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, SNP20, which comprises a G to A nucleotide substitution at position number 221 in SEQ ID NO:6, SNP22, which comprises a T to G nucleotide substitution at position number 160 in SEQ ID NO:7, and SNP24, which comprises a G to A nucleotide substitution at position number 325 in SEQ ID NO:8.

Another embodiment discloses a stevia plant, wherein the leaves of said stevia plant have a RebD content of between 0.6% and 3.3% of dry weight.

Another embodiment discloses a stevia plant, wherein the leaves of said stevia plant have a RebM content of between 0.5% and 1.15% of dry weight.

Another embodiment discloses a stevia plant, wherein the leaves of said stevia plant have a RebD content of between 0.6% and 3.3% of dry weight and a RebM content of between 0.5% and 1.15% of dry weight.

Another embodiment discloses a method for producing a high RebD and high RebM stevia plant comprising: (a) screening a population of stevia plants for at least one of the following SNPs: SNP2, which comprises a G to C nucleotide substitution at position number 225 in SEQ ID NO:1, SNP10, which comprises a G to A nucleotide substitution at position number 187 in SEQ ID NO:2, SNP12, which comprises an C to T nucleotide exchange at position number 345 in SEQ ID NO:3, SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, SNP20, which comprises a G to A nucleotide substitution at position number 221 in SEQ ID NO:6, SNP22, which comprises a T to G nucleotide substitution at position number 160 in SEQ ID NO:7, and SNP24, which comprises a G to A nucleotide substitution at position number 325 in SEQ ID NO:8; (b) selecting a first stevia plant having at least one SNP; (c) crossing the first selected stevia plant having at least one SNP with a second stevia plant having at least one SNP; (d) repeating steps (b) and (c) to obtain stevia plants homozygous for all the SNPs; and (e) screening the stevia plants homozygous for all the SNPs to confirm the presence of all the SNPs in homozygous form to produce a stevia plant, wherein the leaves of the stevia plant have a high RebD content, high RebM content, or a high RebD and high RebM content.

Another embodiment provided herein discloses a stevia plant produced by the breeding method above, wherein the RebD content of the leaves is at least 0.6% of dry weight.

Another embodiment provided herein discloses a stevia plant produced by the breeding method above, wherein the RebM content of the leaves is at least 0.5% of dry weight.

Another embodiment provided herein discloses a stevia plant produced by the breeding method above, wherein the RebD content of the leaves is at least 0.6% of dry weight and wherein the RebM content of the leaves is at least 0.5% of dry weight.

Another embodiment provided herein discloses a method of screening stevia varieties comprising a PCR reaction followed by DNA sequencing, wherein the PCR reaction uses at least one of the following primer sequences: SEQ ID NO:117, SEQ, SEQ ID NO:118, SEQ ID NO:119, SEQ ID No:120, SEQ ID NO:121, SEQ ID NO:122, SEQ ID NO:123, SEQ ID NO:124, SEQ ID NO:125, SEQ ID NO:126, SEQ ID NO:127, SEQ ID NO:128, SEQ ID NO:129, SEQ ID NO:130, SEQ ID NO:131, SEQ ID NO:133, SEQ ID NO:134, SEQ ID NO:135, SEQ ID NO:136, SEQ ID NO:137, and SEQ ID NO:138.

UGT76G1 and UGT91D2 Isoforms Discovery from Transcriptome Sequencing of High RebD and RebM Varieties

Several key UDP-glucosyltransferases (UGTs) are reported to play an important role in the biosynthesis of various steviol glycosides. For instance, UGT76G1 catalyzes the 1-3 β-glycosylation of C-13-O glucose of stevia which results in RebA production. UGT91D2 catalyzes the conversion of RebA to RebD. From RebD, UGT76G1 catalyzes the conversion to RebM. Research by the Applicant has shown that UGT76G1 plays an important role in conversion of Stev to RebA and RebD to RebM. UGT91D2 was reported to convert RebA into RebD.

RNA-Seq (transcriptome sequencing) was employed to discover the various UGT76G1 and UGT91D2 isoforms belonging to high RebD and RebM Stevia rebaudiana leaves. Total RNA was isolated from the leaves of ‘814011’, ‘807086’ and ‘817096’. Messenger RNA were isolated and cDNA libraries were synthesized. Two extraction methods, Trizol or MRIP buffer was used to produce good quality and yield of RNA. Extracted RNA was check using NanoDrop 2000 (Thermo Fisher Scientific Inc., USA), Qubit 2.0 RNA Broad Range Assay (Invitrogen, USA) and Agilent Bioanalyzer RNA Nano chip. RNA samples with RIN 7 and above were selected for library preparation. Messenger RNA isolation and cDNA synthesis was conducted using TruSeq RNA Sample Preparation Kit (Illumina, USA) and SuperScript II Reverse Transcriptase (Invitrogen, USA) according to the manufacturer's protocol. The synthesized cDNA was quantified using Qubit 2.0 DNA Broad Range Assay (Invitrogen, USA). A minimum 20 ng of cDNA was fragmented using Covaris S220 (Covaris Inc, USA) to a targeted size of 200 to 300 base pairs. The fragmented cDNA were then end-repaired, ligated to Illumina TruSeq adapters, and PCR-enriched using TruSeq RNA Sample Preparation Kit (Illumina, USA) according to manufacturer's protocol. The final sequencing libraries were quantified using KAPA kits (KAPA Biosystem, USA) on Agilent Stratagene Mx-3005p quantitative PCR (Agilent, USA) and sizes were confirmed using Agilent Bioanalyzer High Sensitivity DNA Chips (Agilent, USA). Resulting sequencing libraries were sequenced using an Illumina flow cell, and 209 cycles on the Illumina HiSeq 2000 platform (Illumina, USA). The sequencing run generated a total of 128 GB of raw data. Sequences obtained were searched for identity using NCBI (National Centre of Biotechnological Information) BLAST® analysis tool.

Bioinformatics pipeline analysis reveal there are 5 different UGT76G1 isoforms and 31 different UGT91D2 isoforms. Multiple sequence alignment using CLUSTAL W (1.83) software revealed the isolated UGT76G1 and UGT91D2 isoforms are of various lengths and were differentiated among each other by sequence insertion, deletion and mutation. Single Nucleotide Polymorphism (SNPs) and alternative splicing play an important role in generating these variants. Similar isoforms family are identical (99%) across various investigated lines.

For UGT76G1, a total of 5 main isoform families were isolated from each RebD (‘817096’) and RebM lines (‘807086’, ‘814011’). For ‘814011’ these correspond to SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, and SEQ ID NO: 13. For ‘807086’ these correspond to SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, and SEQ ID NO: 18. For ‘817096’ these correspond to SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, and SEQ ID NO: 23.

Multiple sequence alignment of the 5 main UGT76G1 isoforms obtained from ‘814011’ (FIG. 14) revealed that these 5 main different isoforms are differentiated by sequence deletion, insertion and mutation. However, multiple sequence alignments of each of these same isoforms across ‘814011’, ‘807086’ and ‘817096’ (FIG. 15 through FIG. 19) indicated only SNPs play a fundamental role in differentiating this isoforms. FIG. 15 shows the sequence alignment of UGT76G1 isoform sequences SEQ ID NO: 9, SEQ ID NO: 14, and SEQ ID NO: 19 (sequences labelled 1, 2, and 3, respectfully). FIG. 16 shows the sequence alignment of UGT76G1 isoform sequences SEQ ID NO: 10, SEQ ID NO: 15, and SEQ ID NO: 20 (sequences labelled 1, 2, and 3, respectfully). FIG. 17 shows the sequence alignment of UGT76G1 isoform sequences SEQ ID NO: 11, SEQ ID NO: 16, and SEQ ID NO: 21 (sequences labelled 1, 2, and 3, respectfully). FIG. 18 shows the sequence alignment of UGT76G1 isoform sequences SEQ ID NO: 12, SEQ ID NO: 17, and SEQ ID NO: 22 (sequences labelled 1, 2, and 3, respectfully). FIG. 19 shows the sequence alignment of UGT76G1 isoform sequences SEQ ID NO: 13, SEQ ID NO: 18, and SEQ ID NO: 23 (sequences labelled 1, 2, and 3, respectfully).

For UGT91D2, 31 main isoforms were isolated from each RebD (‘817096’) and RebM lines (‘807086’, ‘814011’). For stevia variety ‘817096’ these isoforms correspond to SEQ ID NOs: 24-54. For stevia variety ‘807086’ these isoforms correspond to SEQ ID NOs: 55-85. For stevia variety ‘814011’ these isoforms correspond to SEQ ID NOs: 86-116. A multiple sequence alignment of the 31 isoforms obtained from ‘817096’ revealed some of these different isoforms are differentiated by sequence deletion, insertion and mutation (SNPs) (FIG. 20, SEQ ID NO's: 24-54 are labelled 1-31, respectively). However, multiple sequence alignment of each of these same isoforms across ‘814011’, ‘807086’ and ‘817096’ indicated only SNPs play a fundamental roles in differentiating this isoforms (FIG. 21, alignment of SEQ ID NO: 24 from ‘817096’, SEQ ID NO: 55 from ‘807086’, and SEQ ID NO: 86 from ‘814011’).

These UGT isoforms show variation to those known in public database (National Centre for Biotechnology Information). They are specific to high RebD and RebM lines. UGT isoforms sequences undergo some alternative splicing due to genome rearrangement after many generation of crossings of parental lines. UGT isoforms sequence also have some mutations in the respective nucleotides compare to published sequence.

Thus, another embodiment of the present disclosure is a stevia plant further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein the isoforms correspond to SEQ ID NOs: 19-23, and wherein the stevia plant further comprises isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein the isoforms correspond to SEQ ID NOs: 24-54, and wherein the stevia plant has high RebD content.

Another embodiment discloses a stevia plant further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein the isoforms correspond to SEQ ID NOs: 9-13, and wherein the stevia plant further comprises isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein the isoforms correspond to SEQ ID NOs: 86-116, and wherein the stevia plant has high RebM content.

Another embodiment discloses a stevia plant further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein the isoforms correspond to SEQ ID NOs: 14-18, and wherein the stevia plant further comprises isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein the isoforms correspond to SEQ ID NOs: 55-85, and wherein the stevia plant has high RebM content.

Another embodiment discloses a stevia plant further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein the isoforms correspond to SEQ ID NOs: 9-13, and wherein the stevia plant further comprises isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein the isoforms correspond to SEQ ID NOs: 86-116, and wherein the stevia plant has high RebD content.

Another embodiment discloses a stevia plant further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein the isoforms correspond to SEQ ID NOs: 14-18, and wherein the stevia plant further comprises isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein the isoforms correspond to SEQ ID NOs: 55-85, and wherein the stevia plant has high RebD content.

Another embodiment discloses a method of producing a commodity plant product, comprising obtaining a plant having SNP2, SNP10, SNP12, SNP17, SNP19, SNP20, SNP22, and SNP24, or a part thereof, and producing the commodity plant product from the plant or part thereof, wherein the commodity plant product is a composition of glycosides.

EXAMPLES

The following examples are provided to illustrate further the various applications and are not intended to limit the invention beyond the limitations set forth in the appended claims.

Example 1—SNP17, SNP19, and SNP20 Successfully Predict High RebD and RebM Content

Using probe based genotyping, SNP probes for SNP17, SNP19, and SNP20 were designed and used to screen 38 lines from different genetic backgrounds in 2014 and across 1,000 additional lines in 2015. Probes were designed and synthesized by Integrated DNA Technologies (IDT; Coralville, Iowa). Probes consisted of a fluorescent reporter attached to the 5′ end and a non-fluorescent (quencher) attached to the 3′ end (Table 5A). Primer sequences are referenced in Table 5B.

TABLE 5A Probe designs for SNP17, SNP19, and SNP20 genotyping Probe Probe allele Probe sequence SNP17 SNP17-A 5HEX/TGA + T + A + A + GAT + G + GCT/3IABkFQ SNP17-C 56-FAM/TGA + T + A + C + GA T + GGCT/3IABkFQ SNP19 SNP19-A 56-FAM/TC + G + GT + T + A + GT + CTC/3IABkFQ SNP19-T 5HEX/TC  + G-HGT  + T + T + G T + CT C/3IABkFQ SNP20 SNP20-A 56-FAM/AA  + CA + A  + C + C + C  + TAA C/3IABkFQ SNP20-G 5HEX/AC + A + G-FCC + C + T + AAC/3IABkFQ

TABLE 5B Primer designs for SNP17, SNP19, and SNP20 genotyping Primers Primer Probe sequence SNP17 SNP17-Forward SEQ ID NO: 133 SNP17-Reverse SEQ ID NO: 134 SNP19 SNP19-Forward SEQ ID NO: 135 SNP19-Reverse SEQ ID NO: 136 SNP20 SNP20-Forward SEQ ID NO: 137 SNP20-Reverse SEQ ID NO: 138

DNA was extracted from the frozen leaves of 1,000 different stevia plants with contrasting glycoside compositions using DNeasy Plant Mini kit (Qiagen, Germany). Extracted DNA quantity were analyzed using agarose gel 1% (75 Volt, 60 minutes). Good quality DNA with a concentration around 2 ng was selected for genotyping using each SNP primer and probe set.

Genotyping was performed using the following 45 cycle protocol: (a) an initial 5 minute denaturation at 95° C., with subsequent cycles having a denaturation of 15 seconds at 95° C.; (b) annealing/extension at 60° C. for 30 seconds in Rotor-Gene Q 5 plex HRM system (Qiagen, Germany). For each reaction, the following were used: 10 μl of Type-it Fast SNP Probe PCR Master Mix, 2×; 1 μl of 20× primer-probe mix, 1 μl of genomic DNA and the volume was added with dH₂O until it reach 20 μl. Scatter graph analysis was performed using Rotor-Gene Q Series Software to group all the homozygous dominant, homozygous recessive and heterozygous lines.

From these 1,000 Stevia lines, 120 plants were randomly selected for HPLC analysis, along with the 38 lines from 2014 (Table 6). Based on the presence or absence of these SNPs, plants were predicted to be in one of two groups, either high RebA and/or high Stev, or high RebD and/or high RebM. Following HPLC analysis plants were assigned to one of the following groups based on steviol glycoside content: ST, RA, ST/RA, RD, RM, RD/RM (column 2, Table 6).

The plants were analyzed for rebaudioside content by HPLC as described above and the percent content for rebaudioside for each variety is shown in columns 3 through 15 of Table 6. Column 1 of Table 6 shows the variety, and column 2 of Table 6 shows the group based on steviol glycoside content. High RebD lines are defined as having a RebD content that is ≥0.6% and a RebD/TSG≥8%. High RebM lines are defined as having a RebM content that is ≥0.5%. High RebA lines are defined as having a RebA content that is ≥9%, a RebD content that is ≤0.3%, and a RebM content of ≤0.2%. High Stev lines are defined as having a Stev content of ≥7%, a RebD content of ≤0.3%, and a RebM content of ≤0.2%. Columns labelled RD and RM are in bold. Deposited varieties ‘817096’, ‘814011’, and ‘807086’ are bolded and underlined. RE=rebaudioside E, RO=rebaudioside O, RD=RebD, RN=rebaudioside N, RM=RebM, RA=rebaudioside A, ST=stevioside, RF=rebaudioside F, RC=rebaudioside C, DA=Dulcoside A, RU=rebaudioside U, RB=rebaudioside B, and SB=Steviolbioside. ND=Not Determined.

TABLE 6 SNP genotyping predicts high RebD and RebM content Variety Group RE RO RD RN RM RA ST RF RC DA RU RB SB 412-31 ST ND ND 0.08 ND ND 0.13 8.57 ND 0.02 0.44 ND ND ND 43-2 ST ND ND 0.00 ND ND 0.28 7.87 0.01 0.12 0.53 ND ND ND 49-58 ST ND ND 0.02 ND ND 0.43 11.36 ND 0.02 0.05 ND ND ND 805028 ST ND ND 0.02 ND ND 0.18 9.58 0.01 0.02 0.81 ND ND ND 805003 ST ND ND 0.04 ND ND 0.10 10.13 0.01 0.01 1.05 ND ND ND 803066 ST ND ND 0.01 ND ND 0.26 10.03 0.02 0.03 0.93 ND ND ND 813057 RA ND ND 0.15 ND ND 12.29 0.54 0.21 0.99 ND ND ND ND 812051 RA ND ND 0.17 ND ND 11.44 0.56 0.28 0.91 0.01 ND ND ND 805068 RA ND ND 0.10 ND ND 12.32 1.09 0.06 0.83 ND ND ND ND 815034 RA ND ND 0.20 ND ND 9.51 0.69 0.25 0.77 ND ND ND ND 802057 RA ND ND 0.17 ND ND 11.55 0.56 0.32 1.06 ND ND ND ND 817075 RA ND ND 0.19 ND ND 10.68 0.56 0.08 0.51 ND ND ND ND PC star RA/ST ND ND 0.22 ND ND 7.89 0.91 0.15 1.42 0.18 0.05 ND ND PC1 RA/ST ND ND 0.13 ND ND 5.83 1.82 0.17 0.74 0.03 0.05 0.15 0.07 M3 RA ND ND 0.22 ND ND 9.03 0.99 0.17 1.02 0.02 0.02 ND 0.06 Hybrid RA/ST ND ND 0.16 ND ND 6.81 3.77 0.21 0.96 0.06 0.04 0.04 0.03 805126 RA ND ND 0.25 ND ND 10.77 0.45 0.07 0.63 ND ND ND ND 805082 RA ND ND 0.18 ND ND 10.78 0.65 0.07 0.54 ND ND ND ND 803065 RD/RM ND ND 0.63 ND 0.00 4.13 0.72 0.10 0.42 1.00 ND ND ND 807086 RD/RM 0.04 0.90 1.55 0.36 1.00 4.15 0.21 0.08 0.32 0.00 ND ND ND 814011 RD/RM 0.07 0.88 1.11 0.24 1.12 8.45 0.38 0.21 0.76 0.02 ND ND ND 817096 RD 1.60 0.64 3.28 0.63 0.38 2.35 2.06 0.10 0.50 0.05 ND ND ND 806034 RD ND ND 0.62 ND ND 3.71 0.21 0.09 0.25 ND ND ND ND 830098 RD ND ND 1.03 ND ND 5.51 0.41 0.12 0.53 ND ND ND ND 803071 RD ND ND 0.70 ND ND 4.30 0.44 0.11 0.48 ND ND ND ND 805061 RD ND ND 1.07 ND ND 4.32 0.42 0.04 0.09 0.02 ND ND ND 813081 RD ND ND 0.62 ND ND 4.54 0.30 0.11 0.31 0.01 ND ND ND 806058 RD ND ND 0.83 ND ND 5.32 0.42 0.13 0.38 0.02 ND ND ND 810103 RD ND ND 0.95 ND ND 4.52 0.28 0.15 0.46 ND ND ND ND 801094 RD ND ND 1.62 ND 0.25 5.41 0.63 0.09 0.62 ND ND ND ND 804075 RD ND ND 0.97 ND 0.24 4.35 0.57 0.16 0.41 ND ND ND ND 804038 RD ND ND 2.23 ND 0.48 3.42 0.66 0.05 0.35 ND ND ND ND 801105 RD ND ND 1.14 ND 0.38 7.13 0.33 0.16 0.55 ND ND ND ND 816055 RD ND ND 0.89 ND 0.31 6.94 0.26 0.10 0.47 0.01 ND ND ND 10-43 RD/RM ND ND 1.59 ND 0.68 6.81 1.11 0.16 0.89 ND 0.18 ND ND 10-43-3 RD/RM ND ND 2.55 ND 0.81 5.73 0.93 0.13 0.67 ND 0.02 0.14 0.03 21-11 RD ND ND 0.66 ND 0.29 4.13 0.43 0.10 0.14 ND ND 0.10 0.03 3-6 RD/RM ND ND 0.92 ND 0.63 6.40 0.22 0.14 0.26 ND ND 0.11 0.04 15101060 RA/ST ND ND 0.59 ND ND 8.88 1.86 0.18 0.93 0.01 ND 0.06 0.02 15103014 RA/ST 0.13 0.02 0.26 0.12 0.01 4.22 5.77 0.14 1.02 0.09 0.02 0.01 0.02 15103015 ST 0.38 0.01 0.01 0.01 0.00 0.07 7.13 ND 0.02 0.55 0.02 ND 0.02 15103018 RA/ST 0.30 0.02 0.67 0.23 0.03 5.43 5.59 0.15 0.94 0.06 0.01 0.02 0.03 15103025 RA/ST 0.08 0.01 0.23 0.11 0.05 6.00 2.98 0.13 0.83 0.02 0.01 0.01 0.01 15103045 RA/ST 0.08 0.10 0.32 0.12 0.08 5.51 2.40 0.12 0.73 0.02 ND 0.01 ND 15103052 RA/ST 0.18 0.01 0.25 0.13 0.05 4.14 4.22 0.12 0.73 0.05 0.01 0.02 0.01 15106002 RA/ST 0.19 0.10 0.77 0.26 0.06 5.72 4.28 0.14 0.83 0.04 0.01 0.01 0.02 15106018 RA/ST 0.13 0.09 0.50 0.16 0.12 7.57 1.87 0.16 0.85 0.02 0.01 0.02 0.01 15106021 RA/ST 0.07 0.72 0.34 0.12 0.11 8.59 1.84 0.14 1.00 0.02 ND ND 0.01 15106038 RA/ST 0.21 0.19 0.44 0.13 0.11 1.74 2.54 0.06 0.34 0.05 0.01 ND 0.01 15106047 RA/ST 0.40 0.11 0.71 0.20 0.08 5.53 6.58 0.18 1.08 0.10 0.02 0.02 0.03 15106052 RA ND ND 0.93 ND 0.00 9.85 1.89 0.19 0.96 0.02 ND 0.06 0.02 15107001 RA/ST 0.28 0.15 0.35 0.10 0.13 8.79 3.66 0.19 1.12 0.02 0.02 0.02 0.01 15107005 ST 0.97 0.02 0.01 ND 0.01 0.13 9.82 0.00 0.02 0.70 0.02 ND 0.07 15108016 RA/ST 0.10 0.10 0.42 0.09 0.14 8.87 1.85 0.17 0.86 0.01 0.01 0.04 ND 15111055 RA/ST 0.07 0.10 0.56 0.30 0.17 7.99 2.10 0.13 0.90 0.01 0.13 0.07 0.01 15111074 ST 0.47 0.16 0.37 0.13 0.07 1.87 7.62 0.10 0.81 0.17 0.02 0.01 0.03 15111075 RA 0.08 0.33 0.54 0.19 0.16 9.65 2.09 0.20 1.07 0.01 0.06 0.06 0.01 15112004 RA/ST 0.13 0.16 0.67 0.18 0.16 6.97 1.76 0.14 0.79 0.01 0.01 0.01 ND 15112010 RA/ST 0.16 0.10 0.72 0.18 0.09 6.79 3.93 0.17 0.89 0.02 0.01 0.02 0.02 15112023 RA ND ND 0.75 ND 0.00 9.56 1.80 0.18 1.07 0.01 ND 0.08 0.02 15112046 RA/ST 0.10 0.49 0.51 0.15 0.18 8.31 1.13 0.14 0.77 0.01 0.01 0.02 0.00 15114004 RA/ST ND ND 0.50 ND 0.00 8.86 3.84 0.22 2.08 0.03 0.11 0.06 0.04 15114039 RA 0.31 0.16 0.58 0.17 0.22 10.80 1.91 0.21 1.10 0.01 ND 0.09 0.04 15115008 RA ND ND 0.36 ND 0.00 11.17 1.97 0.23 1.76 0.01 0.09 0.06 0.02 15101010 ST 0.48 0.12 0.53 0.11 0.00 2.33 8.79 0.11 1.03 0.33 0.07 0.03 0.10 15101015 RA/ST 0.13 0.11 0.79 0.26 0.02 5.44 3.21 0.14 0.96 0.03 0.11 0.05 0.08 15102028 RA/ST 0.12 0.02 0.43 0.07 0.01 4.92 3.06 0.14 0.85 0.03 0.07 0.04 0.04 15102057 RA/ST 0.11 0.02 0.34 0.09 0.05 6.86 2.03 0.17 0.85 0.02 0.04 0.04 0.04 15103021 RA 0.01 0.09 0.40 0.06 0.06 9.23 2.28 0.19 1.08 0.02 0.08 0.10 0.06 15103068 RA 0.01 0.06 0.46 0.15 0.06 9.04 1.62 0.18 1.13 0.01 0.07 0.10 0.06 15104003 ST 0.32 0.03 0.39 0.05 0.00 2.71 8.03 0.11 1.10 0.15 0.08 0.04 0.06 15104048 RA/ST 0.19 0.01 0.62 0.06 0.01 4.07 4.51 0.15 0.81 0.06 0.05 0.04 0.06 15105008 RA/ST 0.16 0.15 0.92 0.20 0.07 5.77 3.59 0.16 0.95 0.03 0.10 0.05 0.04 15105063 RA/ST 0.29 0.01 0.29 0.05 0.03 2.76 6.22 0.13 0.86 0.18 0.03 0.03 0.09 15106034 RA/ST 0.03 ND 0.31 0.06 0.03 5.63 1.81 0.15 0.73 0.01 0.06 0.04 0.02 15106067 RA/ST 0.02 0.16 0.68 0.19 0.08 8.33 2.11 0.18 1.00 0.01 0.08 0.06 0.03 15107013 RA/ST 0.15 0.03 0.48 0.13 0.02 3.42 4.50 0.12 0.83 0.09 0.07 0.04 0.05 15107054 RA/ST 0.04 0.01 0.39 0.05 0.05 6.55 2.45 0.18 0.87 0.03 0.04 0.06 0.04 15108012 ST 0.29 0.01 0.44 0.05 0.03 3.22 7.80 0.13 0.91 0.21 0.06 0.03 0.07 15108033 RA/ST 0.11 0.14 0.41 0.05 0.00 4.24 4.08 0.14 0.89 0.06 0.05 0.05 0.05 15109002 ST 0.29 0.06 0.36 0.19 0.01 3.00 7.53 0.12 1.13 0.14 0.07 0.02 0.07 15109008 ST 0.75 0.04 0.00 0.17 0.04 0.09 8.35 0.01 0.09 0.65 0.02 ND 0.08 15110059 RA/ST 0.23 0.01 0.60 0.20 0.00 4.24 3.58 0.14 0.82 0.04 0.02 0.03 0.05 15111007 ST 0.34 0.06 0.33 0.13 0.01 2.48 9.39 0.11 1.02 0.20 0.02 0.03 0.07 15111020 RA/ST 0.22 0.07 0.29 0.10 0.02 5.10 2.00 0.15 0.77 0.02 0.00 0.05 0.02 15112014 RA/ST 0.06 0.12 0.40 0.14 0.07 7.57 2.90 0.19 1.02 0.03 0.01 0.05 0.02 15112035 RA/ST 0.26 0.06 0.53 0.13 0.01 4.15 5.53 0.17 0.84 0.09 0.01 0.05 0.04 15113010 RA/ST 0.04 0.13 0.24 0.14 0.08 8.10 3.69 0.23 1.10 0.04 0.01 0.09 0.03 15113030 RA/ST 0.06 0.02 0.25 0.08 0.01 6.09 4.37 0.23 1.13 0.05 0.02 0.05 0.02 15114011 RA/ST 0.07 0.07 0.11 0.04 0.01 2.59 4.08 0.13 0.62 0.09 0.01 0.03 0.03 15114031 ST 0.71 0.03 0.01 0.01 0.01 0.07 7.43 0.01 0.05 0.48 0.02 0.00 0.04 15115017 RA/ST 0.12 0.14 0.82 0.33 0.06 6.52 3.59 0.17 1.05 0.04 0.01 0.06 0.04 15115037 RA 0.07 0.16 0.51 0.16 0.17 10.17 1.53 0.32 0.99 0.01 0.01 0.06 0.02 15101023 RD 0.66 0.60 3.01 0.65 0.31 2.71 1.06 0.08 0.33 0.01 ND 0.06 0.04 15101045 RD 0.67 0.08 2.23 0.75 0.16 2.07 1.32 0.08 0.33 0.01 0.01 0.06 0.07 15101057 RD/RM 0.17 0.34 1.83 0.46 0.50 4.15 0.50 0.12 0.32 0.01 ND 0.05 0.02 15102008 RD 0.42 0.05 2.27 0.84 0.25 2.64 1.04 0.07 0.29 0.01 ND 0.05 0.04 15102016 RD 0.08 0.30 1.05 0.37 0.35 4.15 0.38 0.07 0.34 ND ND 0.04 ND 15102017 RD 0.07 0.33 0.62 0.36 0.36 3.02 0.39 0.05 0.27 ND 0.01 0.04 0.01 15102048 RD 0.06 0.87 1.09 0.42 0.30 4.09 0.39 0.08 0.33 ND 0.01 0.04 ND 15102049 RD 0.11 0.38 1.56 0.49 0.46 3.34 0.46 0.08 0.30 ND ND 0.03 0.01 15112062 RD 3.26 0.18 1.35 0.22 0.01 0.33 1.41 0.02 0.11 0.04 0.01 0.02 0.07 15102067 RD 1.08 0.01 1.23 0.36 0.03 0.79 2.31 0.03 0.26 0.03 0.01 0.01 0.06 15103002 RD 0.38 0.44 1.50 0.31 0.48 4.70 0.58 0.12 3.72 ND 0.25 0.09 0.06 15103003 RD/RM 0.40 0.51 1.75 0.38 0.52 3.50 0.31 0.09 1.78 ND 0.15 0.07 0.03 15103009 RD 0.63 0.39 2.42 0.45 0.24 2.38 0.99 0.07 0.29 0.01 0.01 0.04 0.03 15103010 RD 0.06 0.49 0.88 0.25 0.29 4.29 0.27 0.07 0.34 ND 0.00 0.04 ND 15104007 RD 0.27 0.31 0.94 0.25 0.41 3.76 0.39 0.10 3.13 ND 0.23 0.04 0.04 15104023 RD 0.33 0.37 1.11 0.27 0.38 3.34 0.33 0.09 1.70 ND 0.14 0.05 0.02 15104030 RD 0.51 0.07 2.59 0.98 0.31 1.96 0.95 0.05 0.29 ND ND 0.04 0.03 15104054 RD/RM 0.49 0.46 1.95 0.51 0.51 3.99 0.46 0.10 1.29 ND 0.11 0.08 0.03 15104058 RD 0.10 0.21 0.71 0.24 0.28 4.14 0.48 0.08 0.35 ND 0.01 0.03 ND 15104059 RD 0.68 0.39 1.83 0.48 0.44 2.59 0.46 0.06 0.25 ND ND 0.03 0.02 15104062 RD 0.45 0.69 2.06 0.53 0.30 3.33 1.20 0.08 0.40 0.01 ND 0.03 0.02 15105018 RD 0.92 0.37 2.52 0.51 0.16 2.17 1.08 0.08 0.28 0.01 ND 0.05 0.04 15105025 RD 0.11 0.43 1.71 0.43 0.47 3.81 0.52 0.09 0.37 ND ND 0.07 0.02 15105031 RD 1.63 0.09 1.52 0.37 0.07 0.56 1.90 0.01 0.21 0.04 ND 0.02 0.06 15105048 RD/RM 0.04 0.52 1.51 0.43 0.58 4.95 0.50 0.10 0.43 0.01 ND 0.09 0.01 15105051 RD 0.07 0.28 1.05 0.27 0.39 2.93 0.28 0.06 0.23 ND 0.01 0.06 0.01 15105056 RD 0.04 0.38 1.23 0.35 0.43 3.75 0.52 0.07 0.33 0.01 0.01 0.06 ND 15105061 RD 1.18 0.54 2.98 0.59 0.27 2.39 1.55 0.08 0.34 0.01 ND 0.05 0.06 15105066 RD 0.38 0.42 1.26 0.29 0.43 4.14 0.29 0.10 2.27 ND 0.18 0.05 0.03 15106015 RD 0.44 0.31 1.03 0.25 0.31 3.64 0.38 0.09 2.64 0.00 0.21 0.05 0.04 15106017 RD 1.42 0.30 2.11 0.42 0.16 1.44 1.61 0.04 0.22 0.02 0.01 0.02 0.04 15106022 RD 0.35 0.38 1.65 0.37 0.20 2.29 0.97 0.06 0.30 0.01 ND 0.03 0.02 15106024 RD 1.31 0.15 1.86 0.52 0.11 1.17 1.75 0.03 0.30 0.02 ND 0.03 0.06 15106028 RD/RM 0.37 0.53 1.05 0.28 0.51 4.76 0.39 0.10 0.41 ND 0.01 0.07 ND 15106049 RD 0.25 0.15 0.82 0.30 0.30 3.35 0.44 0.09 2.82 ND 0.23 0.04 0.03 15106058 RD 0.31 0.35 0.98 0.26 0.37 4.90 0.57 0.10 0.41 ND 0.01 0.08 0.02 15106059 RD 0.22 0.40 1.00 0.24 0.41 4.04 0.29 0.08 0.30 ND ND 0.06 0.01 15107009 RD 0.97 0.43 2.06 0.42 0.13 1.74 1.49 0.04 0.36 0.08 0.01 0.03 0.06 15107022 RD 2.04 0.34 2.87 0.60 0.11 1.80 1.73 0.08 0.43 0.01 0.03 0.09 0.00 15107060 RD 1.63 0.01 2.33 0.66 0.05 1.22 1.38 0.07 0.50 0.04 0.03 0.07 0.03 15107063 RD 1.44 0.01 1.45 0.44 0.03 1.08 2.11 0.05 0.37 0.09 0.01 0.02 0.04 15107066 RD 0.80 0.13 1.85 0.55 0.20 1.93 1.53 0.05 0.34 0.02 ND 0.03 0.04 15108006 RD 1.46 0.01 3.01 0.87 0.16 1.82 1.81 0.07 0.46 0.04 0.01 0.10 0.06 15108014 RD 2.05 ND 2.45 0.69 0.05 0.73 1.65 0.04 0.30 0.03 0.02 0.01 0.05 15108027 RD 1.97 0.26 1.91 0.39 0.04 0.96 1.48 0.06 0.32 0.05 0.01 0.03 0.07 15108043 RD 0.27 0.49 1.98 0.49 0.37 2.49 0.73 0.06 0.28 0.00 0.15 0.04 0.02 15108044 RD 0.23 0.42 1.80 0.47 0.30 4.14 1.26 0.10 0.42 0.01 0.18 0.10 0.05 15109003 RD 0.07 0.35 0.73 0.36 0.39 4.72 0.43 0.07 0.34 ND 0.17 0.10 0.01 15109004 RD 0.32 0.01 1.81 0.75 0.23 3.05 1.30 0.07 0.34 ND 0.19 0.07 0.04 15109018 RD/RM 0.07 0.50 1.28 0.48 0.52 4.02 0.42 0.07 0.27 ND 0.20 0.06 0.01 15110017 RD 0.35 0.04 1.14 0.28 0.03 5.83 4.42 0.19 1.06 0.06 0.06 0.04 0.04 15111003 RD 1.17 0.02 2.59 0.72 0.12 1.53 1.58 0.04 0.33 0.01 ND 0.05 0.07 15110023 RD/RM 0.53 0.57 1.82 0.50 0.57 3.85 0.55 0.08 0.36 0.09 0.01 0.03 0.01 15111050 RD 0.03 0.38 1.27 0.30 0.45 3.40 0.40 0.07 0.28 ND ND 0.04 0.02 15111066 RD 0.31 0.57 2.56 0.59 0.36 2.56 0.80 0.07 0.30 0.01 0.01 0.04 0.03 15113035 RD 1.06 0.38 2.11 0.42 0.12 1.27 2.01 0.05 0.29 0.03 ND 0.01 0.04 15113056 RD 0.36 0.04 2.05 0.71 0.21 2.25 1.47 0.06 0.35 0.01 0.01 0.06 0.05 15113062 RD 0.06 0.27 1.34 0.34 0.34 3.68 0.72 0.09 0.39 ND 0.01 0.08 0.03 15114055 RD 0.26 0.00 2.04 0.82 0.25 3.09 1.26 0.16 1.41 0.01 0.15 0.05 0.05 15114067 RD 0.43 0.48 1.90 0.41 0.23 2.70 1.00 0.15 1.46 0.01 0.17 0.04 0.04 15115007 RD 0.09 0.26 0.97 0.27 0.28 4.89 0.86 0.19 3.26 0.01 0.23 0.07 0.05 15115021 RD 2.06 0.18 2.07 0.44 0.07 1.15 2.23 0.04 0.31 0.04 0.01 0.03 0.11 15115032 RD 0.67 0.03 2.35 0.80 0.18 2.23 1.43 0.06 0.36 0.01 0.01 0.04 0.06 15115067 RD 0.90 0.07 2.16 0.69 0.11 1.07 1.28 0.04 0.30 0.01 ND 0.02 0.03 15115070 RD 0.99 0.01 2.54 0.61 0.08 0.81 2.00 0.02 0.22 0.01 0.01 0.02 0.08

Table 7 below summarizes the HPLC data from Table 6. TSG=total steviol glycoside, RA/TSG is the percent of rebaudioside A out of the total steviol glycoside, RD/TSG is the percent of RebD out of the total steviol glycoside, RM/TSG is the percent of RebM out of the total steviol glycoside, and ST/TSG is the percent of stevioside out of the total steviol glycoside. Columns labelled RD/TSG and RM/TSG are in bold. Deposited varieties ‘817096’, ‘814011’, and ‘807086’ are bolded and underlined.

TABLE 7 Summary of HPLC data from Table 6 Variety Group TSG RA/TSG RD/TSG RM/TSG ST/TSG 412-31 ST 9.24 1.41 0.87 0.00 92.75 43-2 ST 8.81 3.18 0.00 0.00 89.33 49-58 ST 11.88 3.62 0.17 0.00 95.62 805028 ST 10.62 1.69 0.19 0.00 90.21 805003 ST 11.34 0.88 0.35 0.00 89.33 803066 ST 11.28 2.30 0.09 0.00 88.92 813057 RA 14.18 86.67 1.06 0.00 3.81 812051 RA 13.37 85.56 1.27 0.00 4.19 805068 RA 14.40 85.56 0.69 0.00 7.57 815034 RA 11.42 83.27 1.75 0.00 6.04 802057 RA 13.66 84.55 1.24 0.00 4.10 817075 RA 12.02 88.85 1.58 0.00 4.66 PC star RA/ST 10.95 72.05 2.01 1.19 8.31 PC1 RA/ST 9.02 64.63 1.44 0.33 20.18 M3 RA 11.65 77.51 1.89 1.03 8.50 Hybrid RA/ST 12.08 56.37 1.32 0.00 31.21 805126 RA 12.17 88.50 2.05 0.00 3.70 805082 RA 12.22 88.22 1.47 0.00 5.32 807086 RD/RM 8.61 48.20 18.00 11.61 2.44 814011 RD/RM 13.24 63.82 8.38 8.46 2.87 817096 RD 11.59 20.28 28.30 3.28 17.77 806034 RD 4.88 76.02 12.70 0.00 4.30 830098 RD 7.60 72.50 13.55 0.00 5.39 803071 RD 6.03 71.31 11.61 0.00 7.30 805061 RD 5.96 72.48 17.95 0.00 7.05 813081 RD 5.89 77.08 10.53 0.00 5.09 806058 RD 7.10 74.93 11.69 0.00 5.92 810103 RD 6.36 71.07 14.94 0.00 4.40 801094 RD 8.62 62.76 18.79 2.90 7.31 804075 RD 6.70 64.93 14.48 3.58 8.51 804038 RD 7.19 47.57 31.02 6.68 9.18 801105 RD 9.69 73.58 11.76 3.92 3.41 816055 RD 8.98 77.28 9.91 3.45 2.90 10-43 RD/RM 11.59 58.76 13.72 5.87 9.58 10-43-3 RD/RM 10.97 52.23 23.25 7.38 8.48 21-11 RD 5.90 70.00 11.19 4.92 7.29 3-6 RD/RM 8.82 72.56 10.43 7.14 2.49 15101060 RA/ST 12.51 70.94 4.72 0.00 14.83 15103014 RA/ST 11.81 35.73 2.20 0.08 48.81 15103015 ST 8.21 0.87 0.12 0.00 86.85 15103018 RA/ST 13.48 40.28 4.97 0.22 41.47 15103025 RA/ST 10.46 57.36 2.20 0.48 28.49 15103045 RA/ST 9.48 58.15 3.38 0.84 25.33 15103052 RA/ST 9.90 41.77 2.53 0.51 42.58 15106002 RA/ST 12.42 46.05 6.20 0.48 34.42 15106018 RA/ST 11.48 65.94 4.36 1.05 16.25 15106021 RA/ST 12.95 66.32 2.63 0.85 14.21 15106038 RA/ST 5.82 29.84 7.57 1.89 43.68 15106047 RA/ST 15.02 36.78 4.73 0.53 43.77 15106052 RA 13.90 70.83 6.69 0.00 13.60 15107001 RA/ST 14.82 59.30 2.36 0.88 24.70 15107005 ST 11.75 1.06 0.09 0.09 83.53 15108016 RA/ST 12.65 70.08 3.32 1.11 14.58 15111055 RA/ST 12.52 63.78 4.47 1.36 16.73 15111074 ST 11.82 15.79 3.13 0.59 64.45 15111075 RA 14.45 66.81 3.74 1.11 14.47 15112004 RA/ST 10.99 63.45 6.10 1.46 16.02 15112010 RA/ST 13.08 51.93 5.51 0.69 30.02 15112023 RA 13.47 70.97 5.57 0.00 13.36 15112046 RA/ST 11.81 70.39 4.32 1.52 9.53 15114004 RA/ST 15.22 58.18 3.29 0.00 25.20 15114039 RA 15.59 69.28 3.72 1.41 12.22 15115008 RA 15.30 73.00 2.32 0.00 12.85 15101010 ST 14.03 16.61 3.78 0.00 62.65 15101015 RA/ST 11.33 48.01 6.97 0.18 28.33 15102028 RA/ST 9.80 50.20 4.39 0.10 31.22 15102057 RA/ST 10.66 64.35 3.19 0.47 19.04 15103021 RA 13.66 67.57 2.93 0.44 16.69 15103068 RA 12.95 69.81 3.55 0.46 12.51 15104003 ST 13.07 20.73 2.98 0.00 61.44 15104048 RA/ST 10.64 38.25 5.83 0.09 42.39 15105008 RA/ST 12.19 47.33 7.55 0.57 29.45 15105063 RA/ST 10.97 25.16 2.64 0.27 56.70 15106034 RA/ST 8.88 63.40 3.49 0.34 20.38 15106067 RA/ST 12.93 64.42 5.26 0.62 16.32 15107013 RA/ST 9.93 34.44 4.83 0.20 45.32 15107054 RA/ST 10.76 60.87 3.62 0.46 22.77 15108012 ST 13.25 24.30 3.32 0.23 58.87 15108033 RA/ST 10.27 41.29 3.99 0.00 39.73 15109002 ST 12.99 23.09 2.77 0.08 57.97 15109008 ST 10.29 0.87 0.00 0.39 81.15 15110059 RA/ST 9.96 42.57 6.02 0.00 35.94 15111007 ST 14.19 17.48 2.33 0.07 66.17 15111020 RA/ST 8.81 57.89 3.29 0.23 22.70 15112014 RA/ST 12.58 60.17 3.18 0.56 23.05 15112035 RA/ST 11.87 34.96 4.47 0.08 46.59 15113010 RA/ST 13.92 58.19 1.72 0.57 26.51 15113030 RA/ST 12.38 49.19 2.02 0.08 35.30 15114011 RA/ST 7.88 32.87 1.40 0.13 51.78 15114031 ST 8.87 0.89 0.13 0.13 83.77 15115017 RA/ST 12.95 50.35 6.33 0.46 27.72 15115037 RA 14.18 71.72 3.60 1.20 10.79 803065 RD/RM 7.00 59.00 9.00 0.00 10.29 15101023 RD 9.50 28.47 31.68 3.26 11.16 15101045 RD 7.81 26.52 28.57 2.05 16.85 15101057 RD/RM 8.46 49.02 21.64 5.91 5.85 15102008 RD 7.96 33.12 28.54 3.14 13.07 15102016 RD 7.12 58.22 14.75 4.92 5.34 15102017 RD 5.51 54.72 11.25 6.53 7.08 15102048 RD 7.68 53.22 14.20 3.91 5.08 15102049 RD 7.20 46.42 21.68 6.39 6.32 15112062 RD 7.02 4.70 19.24 0.14 20.03 15102067 RD 6.19 12.77 19.89 0.49 37.27 15103002 RD 12.62 37.22 11.89 3.80 4.60 15103003 RD/RM 9.47 36.91 18.48 5.49 3.27 15103009 RD 7.92 29.99 30.56 3.03 12.44 15103010 RD 6.97 61.52 12.63 4.16 3.88 15104007 RD 9.84 38.16 9.55 4.17 3.91 15104023 RD 8.11 41.21 13.70 4.69 4.01 15104030 RD 7.77 25.24 33.35 3.99 12.17 15104054 RD/RM 9.96 40.01 19.58 5.12 4.62 15104058 RD 6.61 62.60 10.75 4.24 7.19 15104059 RD 7.23 35.82 25.31 6.09 6.36 15104062 RD 9.07 36.66 22.71 3.31 13.18 15105018 RD 8.18 26.47 30.81 1.96 13.20 15105025 RD 8.02 47.47 21.33 5.86 6.49 15105031 RD 6.48 8.65 23.47 1.08 29.34 15105048 RD/RM 9.17 53.98 16.47 6.32 5.45 15105051 RD 5.62 52.05 18.68 6.94 4.98 15105056 RD 7.18 52.23 17.13 5.99 7.24 15105061 RD 10.02 23.80 29.74 2.69 15.47 15105066 RD 9.83 42.12 12.82 4.37 2.90 15106015 RD 9.38 38.77 10.99 3.31 4.05 15106017 RD 7.80 18.41 27.07 2.05 20.65 15106022 RD 6.61 34.57 24.96 3.03 14.60 15106024 RD 7.29 16.05 25.51 1.51 23.94 15106028 RD/RM 8.47 56.14 12.40 6.02 4.60 15106049 RD 8.79 38.05 9.33 3.41 4.95 15106058 RD 8.35 58.62 11.74 4.43 6.83 15106059 RD 7.03 57.47 14.22 5.83 4.05 15107009 RD 7.82 22.25 26.34 1.66 19.05 15107022 RD 10.13 17.77 28.33 1.09 17.08 15107060 RD 8.02 15.21 29.05 0.62 17.21 15107063 RD 7.14 15.13 20.31 0.42 29.55 15107066 RD 7.45 25.92 24.85 2.69 20.48 15108006 RD 9.88 18.42 30.47 1.62 18.32 15108014 RD 8.07 9.05 30.36 0.62 20.45 15108027 RD 7.55 12.72 25.30 0.53 19.60 15108043 RD 7.36 33.79 26.92 5.03 9.93 15108044 RD 9.46 43.73 19.04 3.17 13.27 15109003 RD 7.72 61.08 9.46 5.05 5.57 15109004 RD 8.17 37.35 22.17 2.82 15.92 15109018 RD/RM 7.90 50.92 16.21 6.59 5.32 15110017 RD 13.54 43.06 8.42 0.22 32.64 15111003 RD 8.21 18.59 31.57 1.46 19.20 15110023 RD/RM 8.97 42.92 20.29 6.35 6.13 15111050 RD 6.63 51.21 19.16 6.79 5.96 15111066 RD 8.19 31.28 31.28 4.40 9.71 15113035 RD 7.78 16.33 27.14 1.54 25.79 15113056 RD 7.62 29.55 26.92 2.76 19.24 15113062 RD 7.33 50.20 18.28 4.64 9.75 15114055 RD 9.55 32.36 21.36 2.62 13.19 15114067 RD 9.02 29.93 21.06 2.55 11.09 15115007 RD 11.43 42.78 8.49 2.45 7.52 15115021 RD 8.73 13.12 23.72 0.80 25.56 15115032 RD 8.22 27.08 28.61 2.19 17.41 15115067 RD 6.66 16.07 32.43 1.65 19.22 15115070 RD 7.39 10.96 34.37 1.08 27.06

SNP markers for SNP17, SNP19, and SNP20 successfully predict stevia plants having high RebD and/or high RebM, as all plants placed into this grouping based on the presence of these SNPs show high RebD and/or high RebM based on HPLC analysis (Table 6 and Table 7 above). Additionally, this genotyping method can successfully screen out 100% of stevia plants in the RA/ST group, thus facilitating the breeding of only plants having high RebD and RebM.

Shown below in Table 8, the data from Tables 7 and 6 are combined and summarized. Column 1 lists the average, minimum, and maximum values of RD/TSG and RM/TSG, and columns 2 and 3 list the group. For example, the average value of RD/TSG in the RA/ST group is 3.08%, compared to 19.89% in the RD/RM group. Additionally, RD/TSG exhibits a range of 8.38% to 34.37% in the RD/RM group, compared to a range of 0% to 7.57% in the RA/ST group. Similarly, RM/TSG exhibits a range of 0% to 11.61% in the RD/RM group, compared to a range of 0% to 1.89% in the RA/ST group.

TABLE 8 Average, minimum, and maximum values per group RA/ST group RD/RM group average value of RD/TSG 3.08% 19.89% average value of RM/TSG 0.38%  3.44% minimum value RD/TSG   0%  8.38% maximum value RD/TSG 7.57% 34.37% minimum value of RM/TSG   0%    0% maximum value of RM/TSG 1.89% 11.61%

As shown in Tables 6-8 above, SNP probe genotyping for SNP17, SNP19, and SNP20 shows that there is a correlation between specific SNPs and steviol glycosides composition. SNP17, SNP19, and SNP20 successfully predict stevia plants having high RebD and high RebM. Additionally, this genotyping method can successfully screen out 100% of stevia plants in the RA/ST group, thus facilitating the breeding of only plants having high RebD and RebM.

Thus, another embodiment of the instant application discloses stevia plant, wherein the leaves of the stevia plant have a RebD/total steviol glycoside percentage between 8% and 38% and a RebM/total steviol glycoside percentage between 0% and 14% and further comprise the following SNPs in homozygous form: SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, and SNP 20, which comprises a G to A nucleotide substitution at position number 221 in in SEQ ID NO:6.

Another embodiment discloses a stevia plant, wherein the RebD/total steviol glycoside percentage is between 8% and 17% of dry weight, and wherein the RebM/total steviol glycoside percentage is between 0% and 4% of dry weight.

Another embodiment discloses a stevia plant, wherein the RebD/total steviol glycoside percentage is between 17.1% and 27% of dry weight, and wherein the RebM/total steviol glycoside percentage is between 4.1% and 8% of dry weight.

Another embodiment a stevia plant, wherein the RebD/total steviol glycoside percentage is between 27.1% and 38% of dry weight, and wherein the RebM/total steviol glycoside percentage is between 8.1% and 14% of dry weight.

Additional Methods for Detecting SNPs for Marker Assisted Breeding

In addition to the direct or indirect sequencing of the site and the probes described above, the SNPs disclosed herein may also be detected by a variety of effective methods well known in the art including those disclosed in U.S. Pat. Nos. 5,468,613 and 5,217,863; 5,210,015; 5,876,930; 6,030,787 6,004,744; 6,013,431; 5,595,890; 5,762,876; 5,945,283; 5,468,613; 6,090,558; 5,800,944 and 5,616,464. In particular, polymorphisms in DNA sequences can be detected by hybridization to allele-specific oligonucleotide (ASO) probes as disclosed in U.S. Pat. Nos. 5,468,613 and 5,217,863. The nucleotide sequence of an ASO probe is designed to form either a perfectly matched hybrid or to contain a mismatched base pair at the site of the variable nucleotide residues. The distinction between a matched and a mismatched hybrid is based on differences in the thermal stability of the hybrids in the conditions used during hybridization or washing, differences in the stability of the hybrids analyzed by denaturing gradient electrophoresis or chemical cleavage at the site of the mismatch.

If a SNP creates or destroys a restriction endonuclease cleavage site, it will alter the size or profile of the DNA fragments that are generated by digestion with that restriction endonuclease. As such, plants that possess a variant sequence can be distinguished from those having the original sequence by restriction fragment analysis. SNPs that can be identified in this manner are termed “restriction fragment length polymorphisms” (“RFLPs”). RFLPs have been widely used in human and plant genetic analyses (Glassberg, UK Patent Application 2135774; Skolnick et al., Cytogen. Cell Genet 32:58-67 (1982); Botstein et al., Ann. J. Hum. Genet. 32:314-331 (1980); Fischer et al., PCT Application WO 90/13668; Uhlen, PCT Application WO 90/11369.

An alternative method of determining SNPs is based on cleaved amplified polymorphic sequences (CAPS) (Konieczny, A. and F. M. Ausubel, Plant J. 4:403-410 (1993); Lyamichev et al., Science 260:778-783 (1993). A modified version of CAPs, known as dCAPs, is a technique for detection of Single Nucleotide Polymorphisms (SNPs). The dCAPS technique introduces or destroys a restriction enzyme recognition sites by using primers that containing one or more mismatches to the template DNA. The PCR product modified in this manner is then subjected to restriction enzyme digestion and the presence or absence of the SNP is determined by the resulting restriction pattern. This technique is useful for genotyping known mutations and genetic mapping of isolated DNAs (Neff M M, Neff J D, Chory J, Pepper A E. dCAPS, a simple technique for the genetic analysis of single nucleotide polymorphisms: experimental applications in Arabidopsis thaliana genetics. Plant J. 1998 May; 14(3):387-92).

SNPs can also be identified by single strand conformation polymorphism (SSCP) analysis. The SSCP technique is a method capable of identifying most sequence variations in a single strand of DNA, typically between 150 and 250 nucleotides in length (Elles, Methods in Molecular Medicine: Molecular Diagnosis of Genetic Diseases, Humana Press (1996); Orita et al., Genomics 5:874-879 (1989). Under denaturing conditions a single strand of DNA will adopt a conformation that is uniquely dependent on its sequence. This conformation usually will be different even if only a single base is changed. Most conformations have been reported to alter the physical configuration or size sufficiently to be detectable by electrophoresis. A number of protocols have been described for SSCP including, but not limited to Lee et al., Anal. Biochem. 205:289-293 (1992); Suzuki et al., Anal. Biochem. 192:82-84 (1991); Lo et al., Nucleic Acids Research 20:1005-1009 (1992); Sarkar et al., Genomics 13:441-443 (1992).

SNPs may also be detected using a DNA fingerprinting technique called amplified fragment length polymorphism (AFLP), which is based on the selective PCR amplification of restriction fragments from a total digest of genomic DNA to profile that DNA. Vos et al., Nucleic Acids Res.23:4407-4414 (1995). This method allows for the specific co-amplification of many restriction fragments, which can be analyzed without knowledge of the nucleic acid sequence. AFLP employs basically three steps. Initially, a sample of genomic DNA is cut with restriction enzymes and oligonucleotide adapters are ligated to the restriction fragments of the DNA. The restriction fragments are then amplified using PCR by using the adapter and restriction sequence as target sites for primer annealing. The selective amplification is achieved by the use of primers that extend into the restriction fragments, amplifying only those fragments in which the primer extensions match the nucleotide flanking the restriction sites. These amplified fragments are then visualized on a denaturing polyacrylamide gel (Beismann et al., Mol. Ecol. 6:989-993 (1997); Janssen et al., Int. J. Syst. Bacteriol 47:1179-1187 (1997); Huys et al., Int. J. Syst. Bacteriol. 47:1165-1171 (1997); McCouch et al., Plant Mol. Biol. 35:89-99 (1997); Nandi et al., Mol. Gen. Genet. 255:1-8 (1997); Cho et al. Genome 39:373-378 (1996); Simons et al., Genomics 44:61-70 (1997); Cnops et al., Mol. Gen. Genet. 253:32-41 (1996); Thomas et al., Plant J. 8:785-794 (1995).

SNPs may also be detected using random amplified polymorphic DNA (RAPD) (Williams et al., Nucl. Acids Res. 18:6531-6535 (1990).

SNPs can be detected by methods as disclosed in U.S. Pat. Nos. 5,210,015; 5,876,930 and 6,030,787 in which an oligonucleotide probe having reporter and quencher molecules is hybridized to a target polynucleotide. The probe is degraded by 5′→3′ exonuclease activity of a nucleic acid polymerase.

SNPs can also be detected by labelled base extension methods as disclosed in U.S. Pat. Nos. 6,004,744; 6,013,431; 5,595,890; 5,762,876; and 5,945,283. These methods are based on primer extension and incorporation of detectable nucleoside triphosphates. The primer is designed to anneal to the sequence immediately adjacent to the variable nucleotide which can be can be detected after incorporation of as few as one labelled nucleoside triphosphate. U.S. Pat. No. 5,468,613 discloses allele specific oligonucleotide hybridizations where single or multiple nucleotide variations in nucleic acid sequence can be detected in nucleic acids by a process in which the sequence containing the nucleotide variation is amplified, spotted on a membrane and treated with a labelled sequence-specific oligonucleotide probe

Other methods for identifying and detecting SNPs in addition to those described above include the use of restriction enzymes (Botstein et al., Am. J. Hum. Genet. 32:314-331 (1980); and Konieczny and Ausubel, Plant J 4:403-410 (1993)), enzymatic and chemical mismatch assays (Myers et al., Nature 313:495-498 (1985)), allele-specific PCR (Newton et al., Nucl. Acids Res. 17:2503-2516 (1989); and Wu et al., Proc. Natl. Acad. Sci. USA 86:2757-2760 (1989)), ligase chain reaction (Barany, Proc. Natl. Acad. Sci. USA 88:189-193 (1991)), single-strand conformation polymorphismanalysis (Labrune et al., Am. J. Hum. Genet. 48: 1115-1120 (1991)), single base primer extension (Kuppuswamy et al., Proc. Natl. Acad. Sci. USA 88:1143-1147 (1991); and Goelet, U.S. Pat. Nos. 6,004,744 and 5,888,819, solid-phase ELISA-based oligonucleotide ligation assays (Nikiforov et al., Nucl. Acids Res. 22:4167-4175 (1994)), dideoxy fingerprinting (Sarkar et al., Genomics 13:441-443 (1992)), oligonucleotide fluorescence-quenching assays (Livak et al., PCR Methods Appl. 4:357-362 (1995)), 5′-nuclease allele-specific hybridization TaqMan™ assay (Livak et al., Nature Genet. 9:341-342 (1995)), template-directed dye-terminator incorporation (TDI) assay (Chen and Kwok, Nucl. Acids Res. 25:347-353 (1997)), allele-specific molecular beacon assay (Tyagi et al., Nature Biotech. 16: 49-53 (1998)), PinPoint assay (Haff and Smirnov, Genome Res. 7: 378-388 (1997)), dCAPS analysis (Neffetal., Plant J. 14:387-392 (1998)), pyrosequencing (Ronaghi et al, Analytical Biochemistry 267:65-71 (1999); Ronaghi et al PCT application WO 98/13523; and Nyren et al PCT application WO 98/28440), using mass spectrometry e.g., the Masscode™ system (Howbert et al WO 99/05319; Howber et al WO 97/27331), mass spectroscopy (U.S. Pat. No. 5,965,363, invasive cleavage of oligonucleotide probes (Lyamichev et al Nature Biotechnology 17:292-296), and using high density oligonucleotide arrays (Hacia et al Nature Genetics 22:164-167).

While certain methods for detecting SNPs are described herein, other detection methodologies may be utilized. For example, additional methodologies are known and set forth, in Birren et. al., Genome Analysis, 4:135-186, A Laboratory Manual. Mapping Genomes, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1999); Maliga et al., Methods in Plant Molecular Biology. A Laboratory Course Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1995); Paterson, Biotechnology Intelligence Unit: Genome Mapping in Plants, R. G. Landes Co., Georgetown, Tex., and Academic Press, San Diego, Calif. (1996); The Maize Handbook, Freeling and Walbot, eds., Springer-Verlag, New York, N.Y. (1994); Methods in Molecular Medicine: Molecular Diagnosis of Genetic Diseases, Elles, ed., Humana Press, Totowa, N.J. (1996); Clark, ed., Plant Molecular Biology: A Laboratory Manual, Clark, ed., Springer-Verlag, Berlin, Germany (1997).

Additional Methods for Detecting and Measuring Steviol Glycosides

In addition to HPLC, steviol glycosides may be detected and measured by a number of methods well known in the art.

Breeding for High RebD and High RebM Stevia Plants

Different parental lines, Eirete, AKHL1, AKH EM1, AKHL4, AKH/G.8.D and PC Star 2, were selected and grouped accordingly for the crossings conducted in Ganzhou, Jiangxi Province, the People's Republic of China. Three different sets of crossings were conducted. High RebA stevia plants (‘817075’, ‘805082’, ‘805126’, ‘815034’, ‘802057’, ‘801025’, ‘813057’, ‘812051’ and ‘805068’) and high Stev stevia plants (‘805028’, ‘803066’, ‘805003’, ‘43-2’ and ‘49-58’) were used for SNP genotyping and HPLC analysis. High RebD and high RebM lines ‘814011’ and ‘807086’ are derived from different sets of parental crossing (see FIGS. 11 and 12). Other high RebD lines (‘817096’, ‘801094’, ‘804038’, ‘801105’, ‘816055’, ‘804075’, ‘830098’, ‘806058’, ‘810103’, ‘803071’, ‘805061’, ‘813081’, ‘806034’ and ‘803065’) were all derived from the same parental crossings (FIG. 13).

Breeding Methods that may be Combined with SNP Marker Selection

There are numerous steps in the development of any desirable plant germplasm. Plant breeding begins with the analysis and definition of problems and weaknesses of the current germplasm, the establishment of program goals, and the definition of specific breeding objectives. The next step is selection of germplasm that possess the traits to meet the program goals. The goal is to combine in a single cultivar an improved combination of desirable traits from the parental germplasm. In stevia, the important traits leaf yield, earlier maturity, improved leaf quality, rebaudioside content, stevioside content, resistance to diseases and insects, resistance to drought and heat, and improved agronomic traits. Choice of breeding or selection methods depends on the mode of plant reproduction, the heritability of the trait(s) being improved, and the type of cultivar used commercially (e.g., F₁ hybrid cultivar, pureline cultivar, etc.). For highly heritable traits, a choice of superior individual plants evaluated at a single location will be effective, whereas for traits with low heritability, selection should be based on mean values obtained from replicated evaluations of families of related plants. Popular selection methods commonly include pedigree selection, modified pedigree selection, mass selection, and recurrent selection.

The complexity of inheritance influences choice of the breeding method. Backcross breeding is used to transfer one or a few favorable genes for a highly heritable trait into a desirable cultivar. This approach has been used extensively for breeding disease-resistant cultivars. Various recurrent selection techniques are used to improve quantitatively inherited traits controlled by numerous genes. The use of recurrent selection in self-pollinating crops depends on the ease of pollination, the frequency of successful hybrids from each pollination, and the number of hybrid offspring from each successful cross.

Each breeding program should include a periodic, objective evaluation of the efficiency of the breeding procedure. Evaluation criteria vary depending on the goal and objectives, but should include gain from selection per year based on comparisons to an appropriate standard, overall value of the advanced breeding lines, and number of successful cultivars produced per unit of input (e.g., per year, per dollar expended, etc.).

Promising advanced breeding lines are thoroughly tested and compared to popular cultivars in environments representative of the commercial target area(s) for three or more years. The lines having superiority over the popular cultivars are candidates to become new commercial cultivars. Those lines still deficient in a few traits are discarded or utilized as parents to produce new populations for further selection.

These processes, which lead to the final step of marketing and distribution, usually take from seven to twelve years from the time the first cross is made. Therefore, development of new cultivars is a time-consuming process that requires precise forward planning, efficient use of resources, and a minimum of changes in direction.

A most difficult task is the identification of individuals that are genetically superior because for most traits the true genotypic value is masked by other confounding plant traits or environmental factors. One method of identifying a superior plant is to observe its performance relative to other experimental lines and widely grown standard cultivars. For many traits a single observation is inconclusive, and replicated observations over time and space are required to provide a good estimate of a line's genetic worth.

The goal of a commercial stevia breeding program is to develop new, unique, and superior stevia cultivars. The breeder initially selects and crosses two or more parental lines, followed by generation advancement and selection, thus producing many new genetic combinations. The breeder can theoretically generate billions of different genetic combinations via this procedure. The breeder has no direct control over which genetic combinations will arise in the limited population size which is grown. Therefore, two breeders will never develop the same line having the same traits.

Each year, the plant breeder selects the germplasm to advance to the next generation. This germplasm is grown under unique and different geographical, climatic, and soil conditions and further selections are then made, during and at the end of the growing season. The lines which are developed are unpredictable. This unpredictability is because the breeder's selection occurs in unique environments, with no control at the DNA level (using conventional breeding procedures), and with millions of different possible genetic combinations being generated. A breeder of ordinary skill in the art cannot predict the final resulting lines he develops, except possibly in a very gross and general fashion. The same breeder cannot produce, with any reasonable likelihood, the same cultivar twice by using the exact same original parents and the same selection techniques. This unpredictability results in the expenditure of large amounts of research moneys to develop superior new stevia cultivars.

Pureline cultivars of stevia are commonly bred by hybridization of two or more parents followed by selection. The complexity of inheritance, the breeding objectives, and the available resources influence the breeding method. Pedigree breeding, recurrent selection breeding, and backcross breeding are breeding methods commonly used in self-pollinated crops such as stevia. These methods refer to the manner in which breeding pools or populations are made in order to combine desirable traits from two or more cultivars or various broad-based sources. The procedures commonly used for selection of desirable individuals or populations of individuals are called mass selection, plant-to-row selection, and single seed descent or modified single seed descent. One or a combination of these selection methods can be used in the development of a cultivar from a breeding population.

Pedigree breeding is primarily used to combine favorable genes into a totally new cultivar that is different in many traits than either parent used in the original cross. It is commonly used for the improvement of self-pollinating crops. Two parents which possess favorable, complementary traits are crossed to produce an F₁ (filial generation 1). An F₂ population is produced by selfing F₂ plants. Selection of desirable individual plants may begin as early as the F₂ generation wherein maximum gene segregation occurs. Individual plant selection can occur for one or more generations. Successively, seed from each selected plant can be planted in individual, identified rows or hills, known as progeny rows or progeny hills, to evaluate the line and to increase the seed quantity, or to further select individual plants. Once a progeny row or progeny hill is selected as having desirable traits, it becomes what is known as a breeding line that is specifically identifiable from other breeding lines that were derived from the same original population. At an advanced generation (i.e., F₅ or higher) seed of individual lines are evaluated in replicated testing. At an advanced stage the best lines or a mixture of phenotypically similar lines from the same original cross are tested for potential release as new cultivars.

The single seed descent procedure in the strict sense refers to planting a segregating population, harvesting one seed from every plant, and combining these seeds into a bulk, which is planted as the next generation. When the population has been advanced to the desired level of inbreeding, the plants from which lines are derived will each trace to different F₂ individuals. Primary advantages of the seed descent procedures are to delay selection until a high level of homozygosity (e.g., lack of gene segregation) is achieved in individual plants, and to move through these early generations quickly, usually through using winter nurseries.

The modified single seed descent procedures involve harvesting multiple seed (i.e., a single lock or a simple boll) from each plant in a population and combining them to form a bulk. Part of the bulk is used to plant the next generation and part is put in reserve. This procedure has been used to save labor at harvest and to maintain adequate seed quantities of the population.

Selection for desirable traits can occur at any segregating generation (F₂ and above). Selection pressure is exerted on a population by growing the population in an environment where the desired trait is maximally expressed and the individuals or lines possessing the trait can be identified. For instance, selection can occur for disease resistance when the plants or lines are grown in natural or artificially-induced disease environments, and the breeder selects only those individuals having little or no disease and are thus assumed to be resistant.

In addition to phenotypic observations, the genotype of a plant can also be examined. There are many laboratory-based techniques available for the analysis, comparison, and characterization of plant genotype. Among these are Isozyme Electrophoresis, Restriction Fragment Length Polymorphisms (RFLPs), Randomly Amplified Polymorphic DNAs (RAPDs), Arbitrarily Primed Polymerase Chain Reaction (AP-PCR), DNA Amplification Fingerprinting (DAF), Sequence Characterized Amplified Regions (SCARs), Amplified Fragment Length Polymorphisms (AFLPs), Simple Sequence Repeats (SSRs—which are also referred to as Microsatellites), and Single Nucleotide Polymorphisms (SNPs).

Breeding with Molecular Techniques

Targeted genome editing may be achieved by using engineered nucleases. In bacteria, CRISPRs (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of “spacer DNA” from previous exposures to a bacterial virus or plasmid. It is pronounced “crisper”. Upon subsequent exposure to the virus, the bacteria is able to recognize, target, and destroy the foreign DNA. The CRISPR system can be used for gene editing by using the Cas9 nuclease which uses a guide RNA molecule to home in on its target DNA, then induces double stranded breaks in the DNA to disrupt genes or desired sequences. The DNA is then repaired via the non-homologous repair system or the homologous dependent repair system. In the latter case, artificial oligos may be used to insert a new sequence into the cut site. See also US20100076057A1, WO2010075424A2, WO2013126794A1, WO2013142578, WO2013169398, WO2013176772A1, US2013181440A1, US20140017214A1, WO2014011237A1, WO2014022702A2, WO2014071219A1, U.S. Pat. No. 8,697,359B1, and WO2014018423A2.

Isozyme Electrophoresis and RFLPs have been widely used to determine genetic composition. Shoemaker and Olsen, (Molecular Linkage Map of Soybean (Glycine max L. Merr.) pp. 6.131-6.138 in S. J. O'Brien (Ed.) Genetic Maps: Locus Maps of Complex Genomes, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., (1993)) developed a molecular genetic linkage map that consisted of 25 linkage groups with about 365 RFLP, 11 RAPD, three classical markers, and four isozyme loci. See also, Shoemaker, R. C., RFLP Map of Soybean, pp. 299-309, in Phillips, R. L. and Vasil, I. K. (Eds.), DNA-Based Markers in Plants, Kluwer Academic Press, Dordrecht, the Netherlands (1994).

SSR technology is currently the most efficient and practical marker technology; more marker loci can be routinely used and more alleles per marker locus can be found using SSRs in comparison to RFLPs. For example, Diwan and Cregan described a highly polymorphic microsatellite locus in soybean with as many as 26 alleles. Diwan, N. and Cregan, P. B., Theor. Appl. Genet., 95:22-225 (1997). Additional SNPs to those described herein may also be used to identify the unique genetic composition of the invention and progeny varieties retaining that unique genetic composition. Various molecular marker techniques may be used in combination to enhance overall resolution.

Molecular markers, which includes markers identified through the use of techniques such as Isozyme Electrophoresis, RFLPs, RAPDs, AP-PCR, DAF, SCARs, AFLPs, SSRs, and SNPs, may be used in plant breeding. One use of molecular markers is Quantitative Trait Loci (QTL) mapping. QTL mapping is the use of markers which are known to be closely linked to alleles that have measurable effects on a quantitative trait. Selection in the breeding process is based upon the accumulation of markers linked to the positive effecting alleles and/or the elimination of the markers linked to the negative effecting alleles from the plant's genome.

Molecular markers can also be used during the breeding process for the selection of qualitative traits. For example, markers closely linked to alleles or markers containing sequences within the actual alleles of interest can be used to select plants that contain the alleles of interest during a backcrossing breeding program. For example, molecular markers are used in soybean breeding for selection of the trait of resistance to soybean cyst nematode, see U.S. Pat. No. 6,162,967. The markers can also be used to select toward the genome of the recurrent parent and against the markers of the donor parent. Using this procedure can attempt to minimize the amount of genome from the donor parent that remains in the selected plants. It can also be used to reduce the number of crosses back to the recurrent parent needed in a backcrossing program. The use of molecular markers in the selection process is often called Genetic Marker Enhanced Selection. Molecular markers may also be used to identify and exclude certain sources of germplasm as parental varieties or ancestors of a plant by providing a means of tracking genetic profiles through crosses as discussed more fully hereinafter.

Mutation Breeding

Mutation breeding is another method of introducing new traits into stevia varieties. Mutations that occur spontaneously or are artificially induced can be useful sources of variability for a plant breeder. The goal of artificial mutagenesis is to increase the rate of mutation for a desired characteristic. Mutation rates can be increased by many different means including temperature, long-term seed storage, tissue culture conditions, radiation (such as X-rays, Gamma rays, neutrons, Beta radiation, or ultraviolet radiation), chemical mutagens (such as base analogues like 5-bromo-uracil), antibiotics, alkylating agents (such as sulfur mustards, nitrogen mustards, epoxides, ethylenamines, sulfates, sulfonates, sulfones, or lactones), azide, hydroxylamine, nitrous acid, or acridines. Once a desired trait is observed through mutagenesis the trait may then be incorporated into existing germplasm by traditional breeding techniques. Details of mutation breeding can be found in Principles of Cultivar Development by Fehr, Macmillan Publishing Company (1993).

Production of Double Haploids

The production of double haploids can also be used for the development of homozygous varieties in a breeding program. Double haploids are produced by the doubling of a set of chromosomes from a heterozygous plant to produce a completely homozygous individual. For example, see Wan, et al., Theor. Appl. Genet., 77:889-892 (1989).

Descriptions of other breeding methods that are commonly used for different traits and crops can be found in one of several reference books (e.g., Allard (1960); Simmonds (1979); Sneep, et al. (1979); Fehr (1987)).

Proper testing should detect any major faults and establish the level of superiority or improvement over current cultivars. In addition to showing superior performance, there must be a demand for a new cultivar that is compatible with industry standards or which creates a new market. The introduction of a new cultivar will incur additional costs to the seed producer, and to the grower, processor, and consumer, for special advertising, marketing and commercial production practices, and new product utilization. The testing preceding the release of a new cultivar should take into consideration research and development costs as well as technical superiority of the final cultivar. For seed-propagated cultivars, it must be feasible to produce seed easily and economically.

The stevia flower is monoecious in that the male and female structures are in the same flower. The crossed or hybrid seed is produced by manual crosses between selected parents. Floral buds of the parent that is to be the female are emasculated prior to the opening of the flower by manual removal of the male anthers. At flowering, the pollen from flowers of the parent plants designated as male, are manually placed on the stigma of the previous emasculated flower. Seed developed from the cross is known as first generation (F₁) hybrid seed. Planting of this seed produces F₁ hybrid plants of which half their genetic component is from the female parent and half from the male parent. Segregation of genes begins at meiosis thus producing second generation (F₂) seed. Assuming multiple genetic differences between the original parents, each F₂ seed has a unique combination of genes.

Further Embodiments

With the advent of molecular biological techniques that have allowed the isolation and characterization of genes that encode specific protein products, scientists in the field of plant biology developed a strong interest in engineering the genome of plants to contain and express foreign genes, or additional, or modified versions of native, or endogenous, genes (perhaps driven by different promoters) in order to alter the traits of a plant in a specific manner. Such foreign additional and/or modified genes are referred to herein collectively as “transgenes.” Over the last fifteen to twenty years several methods for producing transgenic plants have been developed, in particular embodiments, also relates to transformed versions of the claimed cultivar.

Plant transformation involves the construction of an expression vector which will function in plant cells. Such a vector comprises DNA comprising a gene under control of or operatively linked to a regulatory element (for example, a promoter). The expression vector may contain one or more such operably linked gene/regulatory element combinations. The vector(s) may be in the form of a plasmid, and can be used alone or in combination with other plasmids, to provide transformed stevia plants, using transformation methods as described below to incorporate transgenes into the genetic material of the stevia plant(s).

Expression Vectors for Stevia Transformation: Marker Genes

Expression vectors include at least one genetic marker operably linked to a regulatory element (for example, a promoter) that allows transformed cells containing the marker to be either recovered by negative selection (i e, inhibiting growth of cells that do not contain the selectable marker gene), or by positive selection (i.e., screening for the product encoded by the genetic marker). Many commonly used selectable marker genes for plant transformation are well known in the transformation arts, and include, for example, genes that code for enzymes that metabolically detoxify a selective chemical agent which may be an antibiotic or an herbicide, or genes that encode an altered target which is insensitive to the inhibitor. A few positive selection methods are also known in the art.

One commonly used selectable marker gene for plant transformation is the neomycin phosphotransferase II (nptll), which, when under the control of plant regulatory signals, confers resistance to kanamycin. Fraley, et al., PNAS, 80:4803 (1983). Another commonly used selectable marker gene is the hygromycin phosphotransferase gene which confers resistance to the antibiotic hygromycin. Vanden Elzen, et al., Plant Mol. Biol., 5:299 (1985).

Additional selectable marker genes of bacterial origin that confer resistance to antibiotics include gentamycin acetyl transferase, streptomycin phosphotransferase, and aminoglycoside-3′-adenyl transferase, the bleomycin resistance determinant. Hayford, et al., Plant Physiol., 86:1216 (1988); Jones, et al., Mol. Gen. Genet., 210:86 (1987); Svab, et al., Plant Mol. Biol., 14:197 (1990); Hille, et al., Plant Mol. Biol., 7:171 (1986). Other selectable marker genes confer resistance to herbicides such as glyphosate, glufosinate, or bromoxynil. Comai, et al., Nature, 317:741-744 (1985); Gordon-Kamm, et al., Plant Cell, 2:603-618 (1990); and Stalker, et al., Science, 242:419-423 (1988).

Other selectable marker genes for plant transformation that are not of bacterial origin include, for example, mouse dihydrofolate reductase, plant 5-enolpyruvyl-shikimate-3-phosphate synthase and plant acetolactate synthase. Eichholtz, et al., Somatic Cell Mol. Genet., 13:67 (1987); Shah, et al., Science, 233:478 (1986); Charest, et al., Plant Cell Rep., 8:643 (1990).

Another class of marker genes for plant transformation requires screening of presumptively transformed plant cells rather than direct genetic selection of transformed cells for resistance to a toxic substance such as an antibiotic. These genes are particularly useful to quantify or visualize the spatial pattern of expression of a gene in specific tissues and are frequently referred to as reporter genes because they can be fused to a gene or gene regulatory sequence for the investigation of gene expression. Commonly used genes for screening presumptively transformed cells include β-glucuronidase (GUS), β-galactosidase, luciferase, and chloramphenicol acetyltransferase. Jefferson, R. A., Plant Mol. Biol. Rep., 5:387 (1987); Teeri, et al., EMBO J., 8:343 (1989); Koncz, et al., PNAS, 84:131 (1987); DeBlock, et al., EMBO J. 3:1681 (1984).

In-vivo methods for visualizing GUS activity that do not require destruction of plant tissue are available. Molecular Probes Publication 2908, IMAGENE GREEN, pp. 1-4 (1993) and Naleway, et al., J. Cell Biol., 115:151a (1991). However, these in-vivo methods for visualizing GUS activity have not proven useful for recovery of transformed cells because of low sensitivity, high fluorescent backgrounds, and limitations associated with the use of luciferase genes as selectable markers. A gene encoding Green Fluorescent Protein (GFP) has been utilized as a marker for gene expression in prokaryotic and eukaryotic cells. Chalfie, et al., Science, 263:802 (1994). GFP and mutants of GFP may be used as screenable markers.

Expression Vectors for Stevia Transformation: Promoters

Genes included in expression vectors must be driven by a nucleotide sequence comprising a regulatory element (for example, a promoter). Several types of promoters are now well known in the transformation arts, as are other regulatory elements that can be used alone or in combination with promoters.

As used herein, “promoter” includes reference to a region of DNA upstream from the start of transcription and involved in recognition and binding of RNA polymerase and other proteins to initiate transcription. A “plant promoter” is a promoter capable of initiating transcription in plant cells. Examples of promoters under developmental control include promoters that preferentially initiate transcription in certain tissues, such as leaves, roots, seeds, fibers, xylem vessels, tracheids, or sclerenchyma. Such promoters are referred to as “tissue-preferred.” Promoters which initiate transcription only in certain tissue are referred to as “tissue-specific.” A “cell type” specific promoter primarily drives expression in certain cell types in one or more organs, for example, vascular cells in roots or leaves. An “inducible” promoter is a promoter which is under environmental control. Examples of environmental conditions that may affect transcription by inducible promoters include anaerobic conditions or the presence of light. Tissue-specific, tissue-preferred, cell type specific, and inducible promoters constitute the class of “non-constitutive” promoters. A “constitutive” promoter is a promoter which is active under most environmental conditions.

A. Inducible Promoters:

An inducible promoter is operably linked to a gene for expression in stevia. Optionally, the inducible promoter is operably linked to a nucleotide sequence encoding a signal sequence which is operably linked to a gene for expression in stevia. With an inducible promoter the rate of transcription increases in response to an inducing agent.

Any inducible promoter can be used in the instant invention. See Ward, et al., Plant Mol. Biol., 22:361-366 (1993). Exemplary inducible promoters include, but are not limited to, that from the ACEI system which responds to copper (Mett, et al., PNAS, 90:4567-4571 (1993)); In2 gene from maize which responds to benzenesulfonamide herbicide safeners (Hershey, et al., Mol. Gen. Genet., 227:229-237 (1991) and Gatz, et al., Mol. Gen. Genet., 243:32-38 (1994)); or Tet repressor from Tn10 (Gatz, et al., Mol. Gen. Genet., 227:229-237 (1991)). An example inducible promoter is a promoter that responds to an inducing agent to which plants do not normally respond. An exemplary inducible promoter is the inducible promoter from a steroid hormone gene, the transcriptional activity of which is induced by a glucocorticosteroid hormone (Schena, et al., PNAS, 88:0421 (1991)).

B. Constitutive Promoters:

A constitutive promoter is operably linked to a gene for expression in stevia or the constitutive promoter is operably linked to a nucleotide sequence encoding a signal sequence which is operably linked to a gene for expression in stevia.

Many different constitutive promoters can be utilized in the instant invention. Exemplary constitutive promoters include, but are not limited to, the promoters from plant viruses such as the 35S promoter from CaMV (Odell, et al., Nature, 313:810-812 (1985)) and the promoters from such genes as rice actin (McElroy, et al., Plant Cell, 2:163-171 (1990)); ubiquitin (Christensen, et al., Plant Mol. Biol., 12:619-632 (1989) and Christensen, et al., Plant Mol. Biol., 18:675-689 (1992)); pEMU (Last, et al., Theor. Appl. Genet., 81:581-588 (1991)); MAS (Velten, et al., EMBO J., 3:2723-2730 (1984)); and maize H3 histone (Lepetit, et al., Mol. Gen. Genet., 231:276-285 (1992) and Atanassova, et al., Plant Journal, 2 (3): 291-300 (1992)).

The ALS promoter, XbaI/NcoI fragment 5′ to the Brassica napus ALS3 structural gene (or a nucleotide sequence similarity to said XbaI/NcoI fragment), represents a particularly useful constitutive promoter. See PCT Application No. WO 96/30530.

C. Tissue-Specific or Tissue-Preferred Promoters:

A tissue-specific promoter is operably linked to a gene for expression in stevia. Optionally, the tissue-specific promoter is operably linked to a nucleotide sequence encoding a signal sequence which is operably linked to a gene for expression in stevia. Plants transformed with a gene of interest operably linked to a tissue-specific promoter produce the protein product of the transgene exclusively, or preferentially, in a specific tissue.

Any tissue-specific or tissue-preferred promoter can be utilized in the instant invention. Exemplary tissue-specific or tissue-preferred promoters include, but are not limited to, a root-preferred promoter, such as that from the phaseolin gene (Murai, et al., Science, 23:476-482 (1983) and Sengupta-Gopalan, et al., PNAS, 82:3320-3324 (1985)); a leaf-specific and light-induced promoter, such as that from cab or rubisco (Simpson, et al., EMBO J., 4(11):2723-2729 (1985) and Timko, et al., Nature, 318:579-582 (1985)); an anther-specific promoter, such as that from LAT52 (Twell, et al., Mol. Gen. Genet., 217:240-245 (1989)); a pollen-specific promoter, such as that from Zm13 (Guerrero, et al., Mol. Gen. Genet., 244:161-168 (1993)); or a microspore-preferred promoter, such as that from apg (Twell, et al., Sex. Plant Reprod., 6:217-224 (1993)).

Signal Sequences for Targeting Proteins to Subcellular Compartments

Transport of protein produced by transgenes to a subcellular compartment, such as the chloroplast, vacuole, peroxisome, glyoxysome, cell wall, or mitochondrion, or for secretion into the apoplast, is accomplished by means of operably linking the nucleotide sequence encoding a signal sequence to the 5′ and/or 3′ region of a gene encoding the protein of interest. Targeting sequences at the 5′ and/or 3′ end of the structural gene may determine, during protein synthesis and processing, where the encoded protein is ultimately compartmentalized.

The presence of a signal sequence directs a polypeptide to either an intracellular organelle or subcellular compartment or for secretion to the apoplast. Many signal sequences are known in the art. See, for example, Becker, et al., Plant Mol. Biol., 20:49 (1992); Close, P. S., Master's Thesis, Iowa State University (1993); Knox, C., et al., Plant Mol. Biol., 9:3-17 (1987); Lerner, et al., Plant Physiol., 91:124-129 (1989); Fontes, et al., Plant Cell, 3:483-496 (1991); Matsuoka, et al., PNAS, 88:834 (1991); Gould, et al., J. Cell. Biol., 108:1657 (1989); Creissen, et al., Plant J., 2:129 (1991); Kalderon, et al., Cell, 39:499-509 (1984); Steifel, et al., Plant Cell, 2:785-793 (1990).

Foreign Protein Genes and Agronomic Genes

With transgenic plants, a foreign protein can be produced in commercial quantities. Thus, techniques for the selection and propagation of transformed plants, which are well understood in the art, yield a plurality of transgenic plants which are harvested in a conventional manner, and a foreign protein then can be extracted from a tissue of interest or from total biomass. Protein extraction from plant biomass can be accomplished by known methods which are discussed, for example, by Heney and Orr, Anal. Biochem., 114:92-6 (1981).

According to an embodiment, the transgenic plant provided for commercial production of foreign protein is a stevia plant. In another embodiment, the biomass of interest is seed. For the relatively small number of transgenic plants that show higher levels of expression, a genetic map can be generated, primarily via conventional RFLP, PCR, and SSR analysis, which identifies the approximate chromosomal location of the integrated DNA molecule. For exemplary methodologies in this regard, see Glick and Thompson, Methods in Plant Molecular Biology and Biotechnology, CRC Press, Boca Raton, 269:284 (1993). Map information concerning chromosomal location is useful for proprietary protection of a subject transgenic plant. If unauthorized propagation is undertaken and crosses made with other germplasm, the map of the integration region can be compared to similar maps for suspect plants, to determine if the latter have a common parentage with the subject plant. Map comparisons would involve hybridizations, RFLP, PCR, SSR and sequencing, all of which are conventional techniques.

Likewise, agronomic genes can be expressed in transformed plants. More particularly, plants can be genetically engineered to express various phenotypes of agronomic interest. Exemplary genes implicated in this regard include, but are not limited to, those categorized below:

A. Genes that Confer Resistance to Pests or Disease and that Encode:

1. Plant disease resistance genes. Plant defenses are often activated by specific interaction between the product of a disease resistance gene (R) in the plant and the product of a corresponding avirulence (Avr) gene in the pathogen. A plant variety can be transformed with cloned resistance gene to engineer plants that are resistant to specific pathogen strains. See, for example, Jones, et al., Science, 266:789 (1994) (cloning of the tomato Cf-9 gene for resistance to Cladosporium falvum); Martin, et al., Science, 262:1432 (1993) (tomato Pto gene for resistance to Pseudomonas syringae pv. tomato encodes a protein kinase); Mindrinos, et al., Cell, 78:1089 (1994) (Arabidopsis RSP2 gene for resistance to Pseudomonas syringae).

2. A gene conferring resistance to a pest, such as nematodes. See, e.g., PCT Application No. WO 96/30517; PCT Application No. WO 93/19181.

3. A Bacillus thuringiensis protein, a derivative thereof or a synthetic polypeptide modeled thereon. See, for example, Geiser, et al., Gene, 48:109 (1986), who disclose the cloning and nucleotide sequence of a Bt δ-endotoxin gene. Moreover, DNA molecules encoding δ-endotoxin genes can be purchased from American Type Culture Collection, Manassas, Va., for example, under ATCC Accession Nos. 40098, 67136, 31995, and 31998.

4. A lectin. See, for example, the disclosure by Van Damme, et al., Plant Molec. Biol., 24:25 (1994), who disclose the nucleotide sequences of several Clivia miniata mannose-binding lectin genes.

5. A vitamin-binding protein such as avidin. See PCT Application No. US 93/06487. The application teaches the use of avidin and avidin homologues as larvicides against insect pests.

6. An enzyme inhibitor, for example, a protease or proteinase inhibitor or an amylase inhibitor. See, for example, Abe, et al., J. Biol. Chem., 262:16793 (1987) (nucleotide sequence of rice cysteine proteinase inhibitor); Huub, et al., Plant Molec. Biol., 21:985 (1993) (nucleotide sequence of cDNA encoding tobacco proteinase inhibitor I); Sumitani, et al., Biosci. Biotech. Biochem., 57:1243 (1993) (nucleotide sequence of Streptomyces nitrosporeus α-amylase inhibitor); and U.S. Pat. No. 5,494,813 (Hepher and Atkinson, issued Feb. 27, 1996).

7. An insect-specific hormone or pheromone, such as an ecdysteroid and juvenile hormone, a variant thereof, a mimetic based thereon, or an antagonist or agonist thereof. See, for example, the disclosure by Hammock, et al., Nature, 344:458 (1990), of baculovirus expression of cloned juvenile hormone esterase, an inactivator of juvenile hormone.

8. An insect-specific peptide or neuropeptide which, upon expression, disrupts the physiology of the affected pest. For example, see the disclosures of Regan, J. Biol. Chem., 269:9 (1994) (expression cloning yields DNA coding for insect diuretic hormone receptor) and Pratt, et al., Biochem. Biophys. Res. Comm., 163:1243 (1989) (an allostatin is identified in Diploptera puntata). See also, U.S. Pat. No. 5,266,317 to Tomalski, et al., who disclose genes encoding insect-specific, paralytic neurotoxins.

9. An insect-specific venom produced in nature by a snake, a wasp, etc. For example, see Pang, et al., Gene, 116:165 (1992), for disclosure of heterologous expression in plants of a gene coding for a scorpion insectotoxic peptide.

10. An enzyme responsible for a hyper-accumulation of a monoterpene, a sesquiterpene, a steroid, a hydroxamic acid, a phenylpropanoid derivative, or another non-protein molecule with insecticidal activity.

11. An enzyme involved in the modification, including the post-translational modification, of a biologically active molecule. For example, a glycolytic enzyme, a proteolytic enzyme, a lipolytic enzyme, a nuclease, a cyclase, a transaminase, an esterase, a hydrolase, a phosphatase, a kinase, a phosphorylase, a polymerase, an elastase, a chitinase, and a glucanase, whether natural or synthetic. See PCT Application No. WO 93/02197 in the name of Scott, et al., which discloses the nucleotide sequence of a callase gene. DNA molecules which contain chitinase-encoding sequences can be obtained, for example, from the ATCC under Accession Nos. 39637 and 67152. See also, Kramer, et al., Insect Biochem. Molec. Biol., 23:691 (1993), who teach the nucleotide sequence of a cDNA encoding tobacco hornworm chitinase, and Kawalleck, et al., Plant Molec. Biol., 21:673 (1993), who provide the nucleotide sequence of the parsley ubi4-2 polyubiquitin gene.

12. A molecule that stimulates signal transduction. For example, see the disclosure by Botella, et al., Plant Molec. Biol., 24:757 (1994), of nucleotide sequences for mung bean calmodulin cDNA clones and Griess, et al., Plant Physiol., 104:1467 (1994), who provide the nucleotide sequence of a maize calmodulin cDNA clone.

13. A hydrophobic moment peptide. See PCT Application No. WO 95/16776 (disclosure of peptide derivatives of Tachyplesin which inhibit fungal plant pathogens) and PCT Application No. WO 95/18855 (teaches synthetic antimicrobial peptides that confer disease resistance).

14. A membrane permease, a channel former or a channel blocker. For example, see the disclosure of Jaynes, et al., Plant Sci., 89:43 (1993), of heterologous expression of a cecropin-β-lytic peptide analog to render transgenic tobacco plants resistant to Pseudomonas solanacearum.

15. A viral-invasive protein or a complex toxin derived therefrom. For example, the accumulation of viral coat proteins in transformed plant cells imparts resistance to viral infection and/or disease development effected by the virus from which the coat protein gene is derived, as well as by related viruses. See, Beachy, et al., Ann. Rev. Phytopathol., 28:451 (1990). Coat protein-mediated resistance has been conferred upon transformed plants against alfalfa mosaic virus, cucumber mosaic virus, tobacco streak virus, potato virus X, potato virus Y, tobacco etch virus, tobacco rattle virus and tobacco mosaic virus. Id.

16. An insect-specific antibody or an immunotoxin derived therefrom. Thus, an antibody targeted to a critical metabolic function in the insect gut would inactivate an affected enzyme, killing the insect. See, Taylor, et al., Abstract #497, Seventh Intl Symposium on Molecular Plant-Microbe Interactions (Edinburgh, Scotland) (1994) (enzymatic inactivation in transgenic tobacco via production of single-chain antibody fragments).

17. A virus-specific antibody. See, for example, Tavladoraki, et al., Nature, 366:469 (1993), who show that transgenic plants expressing recombinant antibody genes are protected from virus attack.

18. A developmental-arrestive protein produced in nature by a pathogen or a parasite. Thus, fungal endo-α-1,4-D-polygalacturonases facilitate fungal colonization and plant nutrient release by solubilizing plant cell wall homo-α-1,4-D-galacturonase. See, Lamb, et al., Bio/technology, 10:1436 (1992). The cloning and characterization of a gene which encodes a bean endopolygalacturonase-inhibiting protein is described by Toubart, et al., Plant J., 2:367 (1992).

19. A developmental-arrestive protein produced in nature by a plant. For example, Logemann, et al., Bio/technology, 10:305 (1992), have shown that transgenic plants expressing the barley ribosome-inactivating gene have an increased resistance to fungal disease.

B. Genes that Confer Resistance to an Herbicide:

1. An herbicide that inhibits the growing point or meristem, such as an imidazolinone or a sulfonylurea. Exemplary genes in this category code for mutant ALS and AHAS enzyme as described, for example, by Lee, et al., EMBO J., 7:1241 (1988), and Miki, et al., Theor. Appl. Genet., 80:449 (1990), respectively. Other herbicides such as dicamba increase plant growth.

2. Glyphosate (resistance conferred by mutant 5-enolpyruvlshikimate-3-phosphate synthase (EPSPS) and aroA genes, respectively) and other phosphono compounds such as glufosinate (phosphinothricin acetyl transferase (PAT) and Streptomyces hygroscopicus PAT bar genes), and pyridinoxy or phenoxy proprionic acids and cyclohexones (ACCase inhibitor-encoding genes). See, for example, U.S. Pat. No. 4,940,835 to Shah, et al., which discloses the nucleotide sequence of a form of EPSP which can confer glyphosate resistance. A DNA molecule encoding a mutant aroA gene can be obtained under ATCC Accession No. 39256, and the nucleotide sequence of the mutant gene is disclosed in U.S. Pat. No. 4,769,061 to Comai. European Patent Application No. 0 333 033 to Kumada, et al., and U.S. Pat. No. 4,975,374 to Goodman, et al., disclose nucleotide sequences of glutamine synthetase genes which confer resistance to herbicides such as L-phosphinothricin or cyclohexanedione. The nucleotide sequence of a PAT gene is provided in European Application No. 0 242 246 to Leemans, et al. DeGreef, et al., Bio/technology, 7:61 (1989), describe the production of transgenic plants that express chimeric bar genes coding for PAT activity. Exemplary of genes conferring resistance to phenoxy proprionic acids and cyclohexones, such as sethoxydim and haloxyfop are the Accl-S1, Accl-S2, and Accl-S3 genes described by Marshall, et al., Theor. Appl. Genet., 83:435 (1992).

3. An herbicide that inhibits photosynthesis, such as a triazine (psbA and gs+ genes) bromoxynil or a benzonitrile (nitrilase gene). Przibila, et al., Plant Cell, 3:169 (1991), describe the transformation of Chlamydomonas with plasmids encoding mutant psbA genes. Nucleotide sequences for nitrilase genes are disclosed in U.S. Pat. No. 4,810,648 to Stalker, and DNA molecules containing these genes are available under ATCC Accession Nos. 53435, 67441, and 67442. Cloning and expression of DNA coding for a glutathione S-transferase is described by Hayes, et al., Biochem. J., 285:173 (1992).

4. Herbicides that inhibit protox, including many different structural classes of molecules (Duke et al., Weed Sci. 39: 465 (1991); Nandihalli et al., Pesticide Biochem, Physiol. 43: 193 (1992); Matringe et al., FEBS Lett. 245: 35 (1989); Yanase and Andoh, Pesticide Biochem. Physiol. 35: 70 (1989)), including the diphenylethers {e.g. acifluorifen, 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobezoic acid, its methyl ester, or oxyfluorfen, 2-chloro-1-(3-ethoxy-4-nitrophenoxy)-4-(trifluorobenzene)}, oxidiazoles (e.g. oxidiazon, 3-chloro-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-(3H)-one), cyclic imides (e.g. S-23142, N-(4-chloro-2-fluoro-5-propargyloxyphenyl)-3,4,5,6-tetrahydrophthalimide; chlorophthalim, N-(4-chlorophenyl)-3,4,5,6-tetrahydrophthalimide), phenyl pyrazoles TNPP-ethyl, ethyl 2-[1-(2,3,4-trichlorophenyl)-4-nitropyrazolyl-5-oxy]propionate; M&B 39279), pyridine derivatives (e.g. LS 82-556), and phenopylate and its O-phenylpyrrolidino- and piperidinocarbamate analogs.

C. Genes that Confer or Contribute to a Value-Added Trait, Such as:

1. Modified fatty acid metabolism, for example, by transforming a plant with an antisense gene of stearyl-ACP desaturase to increase stearic acid content of the plant. See Knultzon, et al., PNAS, 89:2624 (1992).

2. Decreased phytate content: (a) Introduction of a phytase-encoding gene would enhance breakdown of phytate, adding more free phosphate to the transformed plant. See, for example, Van Hartingsveldt, et al., Gene, 127:87 (1993), for a disclosure of the nucleotide sequence of an Aspergillus niger phytase gene; and (b) A gene could be introduced that reduced phytate content. For example, in maize, this could be accomplished by cloning and then reintroducing DNA associated with the single allele, which is responsible for maize mutants characterized by low levels of phytic acid. See, Raboy, et al., Maydica, 35:383 (1990).

3. Modified carbohydrate composition effected, for example, by transforming plants with a gene coding for an enzyme that alters the branching pattern of starch. See, Shiroza, et al., J. Bacteol., 170:810 (1988) (nucleotide sequence of Streptococcus mutants fructosyltransferase gene); Steinmetz, et al., Mol. Gen. Genet., 20:220 (1985) (nucleotide sequence of Bacillus subtilis levansucrase gene); Pen, et al., Bio/technology, 10:292 (1992) (production of transgenic plants that express Bacillus licheniformis α-amylase); Elliot, et al., Plant Molec. Biol., 21:515 (1993) (nucleotide sequences of tomato invertase genes); Sorgaard, et al., J. Biol. Chem., 268:22480 (1993) (site-directed mutagenesis of barley α-amylase gene); and Fisher, et al., Plant Physiol., 102:1045 (1993) (maize endosperm starch branching enzyme II).

4. Modified fiber characteristics, such as fiber quality represent another example of a trait that may be modified in stevia varieties. For example, U.S. Pat. No. 6,472,588 describes transgenic stevia plants transformed with a sucrose phosphate synthase nucleic acid to alter fiber characteristics such as strength, length, fiber fineness, fiber maturity ratio, immature fiber content, fiber uniformity, and micronaire. Stevia plants comprising one or more genes coding for an enzyme selected from the group consisting of endoxyloglucan transferase, catalase and peroxidase for the improvement of stevia fiber characteristics are also described in U.S. Pat. No. 6,563,022. Stevia fiber modification using ovary-tissue transcriptional factors preferentially directing gene expression in ovary tissue, particularly in very early fruit development, utilized to express genes encoding isopentenyl transferase in stevia ovule tissue and modify the characteristics of boll set in stevia plants and alter fiber quality characteristics including fiber dimension and strength is discussed in U.S. Pat. No. 6,329,570. A gene controlling the fiber formation mechanism in stevia plants is described in U.S. Pat. No. 6,169,174. Genes involved in lignin biosynthesis are described in U.S. Pat. No. 5,451,514.

Methods for Stevia Transformation

Numerous methods for plant transformation have been developed, including biological and physical, plant transformation protocols. See, for example, Mild, et al., “Procedures for Introducing Foreign DNA into Plants” in Methods in Plant Molecular Biology and Biotechnology, Glick and Thompson (Eds.), CRC Press, Inc., Boca Raton, pp. 67-88 (1993). In addition, expression vectors and in vitro culture methods for plant cell or tissue transformation and regeneration of plants are available. See, for example, Gruber, et al., “Vectors for Plant Transformation” in Methods in Plant Molecular Biology and Biotechnology, Glick and Thompson (Eds.), CRC Press, Inc., Boca Raton, pp. 89-119 (1993).

A. Agrobacterium-Mediated Transformation:

One method for introducing an expression vector into plants is based on the natural transformation system of Agrobacterium. See, for example, Horsch, et al., Science, 227:1229 (1985). A. tumefaciens and A. rhizogenes are plant pathogenic soil bacteria which genetically transform plant cells. The Ti and Ri plasmids of A. tumefaciens and A. rhizogenes, respectively, carry genes responsible for genetic transformation of the plant. See, for example, Kado, C. I., Crit. Rev. Plant Sci., 10:1 (1991). Descriptions of Agrobacterium vector systems and methods for Agrobacterium-mediated gene transfer are provided by Gruber, et al., supra, Miki, et al., supra, and Moloney, et al., Plant Cell Rep., 8:238 (1989). See also, U.S. Pat. No. 5,563,055 (Townsend and Thomas), issued Oct. 8, 1996.

B. Direct Gene Transfer:

Several methods of plant transformation, collectively referred to as direct gene transfer, have been developed as an alternative to Agrobacterium-mediated transformation. A generally applicable method of plant transformation is microprojectile-mediated transformation wherein DNA is carried on the surface of microprojectiles measuring 1 μm to 4 μm. The expression vector is introduced into plant tissues with a biolistic device that accelerates the microprojectiles to speeds of 300 m/s to 600 m/s which is sufficient to penetrate plant cell walls and membranes. Sanford, et al., Part. Sci. Technol., 5:27 (1987); Sanford, J. C., Trends Biotech., 6:299 (1988); Klein, et al., Bio/technology, 6:559-563 (1988); Sanford, J. C., Physiol Plant, 7:206 (1990); Klein, et al., Bio/technology, 10:268 (1992). See also, U.S. Pat. No. 5,015,580 (Christou, et al.), issued May 14, 1991; U.S. Pat. No. 5,322,783 (Tomes, et al.), issued Jun. 21, 1994.

Another method for physical delivery of DNA to plants is sonication of target cells. Zhang, et al., Bio/technology, 9:996 (1991). Alternatively, liposome and spheroplast fusion have been used to introduce expression vectors into plants. Deshayes, et al., EMBO J., 4:2731 (1985); Christou, et al., PNAS, 84:3962 (1987). Direct uptake of DNA into protoplasts using CaCl₂ precipitation, polyvinyl alcohol, or poly-L-ornithine has also been reported. Hain, et al., Mol. Gen. Genet., 199:161 (1985) and Draper, et al., Plant Cell Physiol. 23:451 (1982). Electroporation of protoplasts and whole cells and tissues has also been described. Donn, et al., In Abstracts of Vllth International Congress on Plant Cell and Tissue Culture IAPTC, A2-38, p. 53 (1990); D'Halluin, et al., Plant Cell, 4:1495-1505 (1992); and Spencer, et al., Plant Mol. Biol., 24:51-61 (1994).

Following transformation of stevia target tissues, expression of the above-described selectable marker genes allows for preferential selection of transformed cells, tissues, and/or plants, using regeneration and selection methods now well known in the art.

The foregoing methods for transformation would typically be used for producing a transgenic variety. The transgenic variety could then be crossed, with another (non-transformed or transformed) variety, in order to produce a new transgenic variety. Alternatively, a genetic trait which has been engineered into a particular stevia cultivar using the foregoing transformation techniques could be moved into another cultivar using traditional backcrossing techniques that are well known in the plant breeding arts. For example, a backcrossing approach could be used to move an engineered trait from a public, non-elite variety into an elite variety, or from a variety containing a foreign gene in its genome into a variety or varieties which do not contain that gene. As used herein, “crossing” can refer to a simple X by Y cross, or the process of backcrossing, depending on the context.

C. Single-Gene Conversion

When the term “stevia plant” is used herein, this also includes any single gene conversions of that variety. The term “single gene converted plant” as used herein refers to those stevia plants which are developed by a plant breeding technique called backcrossing wherein essentially all of the desired morphological and physiological characteristics of a variety are recovered in addition to the single gene transferred into the variety via the backcrossing technique. Backcrossing methods can be used herein to improve or introduce a characteristic into the variety. The term “backcrossing” as used herein refers to the repeated crossing of a hybrid progeny back to the recurrent parent, i.e., backcrossing 1, 2, 3, 4, 5, 6, 7, 8, 9, or more times to the recurrent parent. The parental stevia plant which contributes the gene for the desired characteristic is termed the “nonrecurrent” or “donor parent”. This terminology refers to the fact that the nonrecurrent parent is used one time in the backcross protocol and therefore does not recur. The parental stevia plant to which the gene or genes from the nonrecurrent parent are transferred is known as the recurrent parent as it is used for several rounds in the backcrossing protocol (Poehlman & Sleper (1994); Fehr (1987)). In a typical backcross protocol, the original variety of interest (recurrent parent) is crossed to a second variety (nonrecurrent parent) that carries the single gene of interest to be transferred. The resulting progeny from this cross are then crossed again to the recurrent parent and the process is repeated until a stevia plant is obtained wherein essentially all of the desired morphological and physiological characteristics of the recurrent parent are recovered in the converted plant, in addition to the single transferred gene from the nonrecurrent parent, as determined at the 5% significance level when grown in the same environmental conditions.

The selection of a suitable recurrent parent is an important step for a successful backcrossing procedure. The goal of a backcross protocol is to alter or substitute a single trait or characteristic in the original variety. To accomplish this, a single gene of the recurrent variety is modified or substituted with the desired gene from the nonrecurrent parent, while retaining essentially all of the rest of the desired genetic, and therefore the desired physiological and morphological, constitution of the original variety. The choice of the particular nonrecurrent parent will depend on the purpose of the backcross. One of the major purposes is to add some commercially desirable, agronomically important trait to the plant. The exact backcrossing protocol will depend on the characteristic or trait being altered to determine an appropriate testing protocol. Although backcrossing methods are simplified when the characteristic being transferred is a dominant allele, a recessive allele may also be transferred. In this instance it may be necessary to introduce a test of the progeny to determine if the desired characteristic has been successfully transferred.

Many single gene traits have been identified that are not regularly selected for in the development of a new variety but that can be improved by backcrossing techniques. Single gene traits may or may not be transgenic. Examples of these traits include but are not limited to, male sterility, waxy starch, herbicide resistance, resistance for bacterial, fungal, or viral disease, insect resistance, male fertility, enhanced nutritional quality, industrial usage, yield stability, and yield enhancement. These genes are generally inherited through the nucleus. Several of these single gene traits are described in U.S. Pat. Nos. 5,959,185; 5,973,234; and 5,977,445, the disclosures of which are specifically hereby incorporated by reference.

Further reproduction of the variety can occur by tissue culture and regeneration. Tissue culture of various tissues of stevia and regeneration of plants therefrom is well known and widely published. For example, reference may be had to Komatsuda, T., et al., Crop Sci., 31:333-337 (1991); Stephens, P. A., et al., Theor. Appl. Genet., 82:633-635 (1991); Komatsuda, T., et al., Plant Cell, Tissue and Organ Culture, 28:103-113 (1992); Dhir, S., et al. Plant Cell Rep., 11:285-289 (1992); Pandey, P., et al., Japan J. Breed., 42:1-5 (1992); and Shetty, K., et al., Plant Science, 81:245-251 (1992); as well as U.S. Pat. No. 5,024,944 issued Jun. 18, 1991 to Collins, et al., and U.S. Pat. No. 5,008,200 issued Apr. 16, 1991 to Ranch, et al. Thus, another aspect of this invention is to provide cells which upon growth and differentiation produce stevia plants having high RebD and RebM as well as the markers SNPs disclosed herein.

As used herein, the term “tissue culture” indicates a composition comprising isolated cells of the same or a different type or a collection of such cells organized into parts of a plant. Exemplary types of tissue cultures are protoplasts, calli, plant clumps, and plant cells that can generate tissue culture that are intact in plants or parts of plants, such as embryos, pollen, flowers, seeds, leaves, stems, roots, root tips, anthers, pistils, and the like. Means for preparing and maintaining plant tissue culture are well known in the art. By way of example, a tissue culture comprising organs has been used to produce regenerated plants. U.S. Pat. Nos. 5,959,185; 5,973,234; and 5,977,445, described certain techniques.

Methods for Extraction and Purification of Glycosides

Methods for the extraction and purification of sweet glycosides from the Stevia rebaudiana plant using water or organic solvents are described in, for example, U.S. Pat. Nos. 4,361,697; 4,082,858; 4,892,938; 5,972,120; 5,962,678; 7,838,044 and 7,862,845. Processes for the extraction of RebD are described in U.S. Pat. No. 9,029,426, and the extraction of RebM are provided in U.S. application Ser. No. 14/254,653.

The compositions can be used as sweetness enhancers, flavor enhancers and sweeteners in various food and beverage products. Examples of food and beverage products include, but are not limited to, carbonated soft drinks, ready to drink beverages, energy drinks, isotonic drinks, low-calorie drinks, zero-calorie drinks, sports drinks, teas, fruit and vegetable juices, juice drinks, dairy drinks, yoghurt drinks, alcohol beverages, powdered beverages, bakery products, cookies, biscuits, baking mixes, cereals, confectioneries, candies, toffees, chewing gum, dairy products, flavored milk, yoghurts, flavored yoghurts, cultured milk, soy sauce and other soy base products, salad dressings, mayonnaise, vinegar, frozen-desserts, meat products, fish-meat products, bottled and canned foods, tabletop sweeteners, fruits and vegetables. Additionally the compositions can be used in drug or pharmaceutical preparations and cosmetics, including but not limited to toothpaste, mouthwash, cough syrup, chewable tablets, lozenges, vitamin preparations, and the like. The compositions can be used “as-is” or in combination with other sweeteners, flavors and food ingredients.

DEPOSIT INFORMATION

A deposit of live plant tissue of the stevia variety named ‘807086’ disclosed above and recited in the appended claims has been made with the China General Microbiological Culture Collection Center (CGMCC), Institute of Microbiology, Chinese Academy of Sciences, Datun Road, Chaoyang District 100101 China. The date of deposit was Sep. 24, 2014. The CGMCC accession number is CGMCC No. 9702. All restrictions upon the deposit have been removed, and the deposit is intended to meet all of the requirements of 37 C.F.R. § 1.801-1.809.

A deposit of live plant tissue of the stevia variety named ‘817096’ disclosed above and recited in the appended claims has been made with the China General Microbiological Culture Collection Center (CGMCC), Institute of Microbiology, Chinese Academy of Sciences, Datun Road, Chaoyang District 100101 China. The date of deposit was Sep. 24, 2014. The CGMCC accession number is CGMCC No. 9703. All restrictions upon the deposit have been removed, and the deposit is intended to meet all of the requirements of 37 C.F.R. § 1.801-1.809.

A deposit of live plant tissue of the stevia variety named ‘814011’ disclosed above and recited in the appended claims has been made with the China General Microbiological Culture Collection Center (CGMCC), Institute of Microbiology, Chinese Academy of Sciences, Datun Road, Chaoyang District 100101 China. The date of deposit was Sep. 24, 2014. The CGMCC accession number is CGMCC No. 9701. All restrictions upon the deposit have been removed, and the deposit is intended to meet all of the requirements of 37 C.F.R. § 1.801-1.809.

While a number of exemplary aspects and embodiments have been discussed above, those of skill in the art will recognize certain modifications, permutations, additions, and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter are interpreted to include all such modifications, permutations, additions, and sub-combinations as are within their true spirit and scope. 

What is claimed is:
 1. A stevia plant comprising eight single nucleotide polymorphisms (SNPs), wherein said SNPs are found in homozygous form, wherein said eight SNPs comprise: SNP2, which comprises a G to C nucleotide substitution at position number 225 in SEQ ID NO:1, SNP10, which comprises a G to A nucleotide substitution at position number 187 in SEQ ID NO:2, SNP12, which comprises a C to T nucleotide exchange at position number 345 in SEQ ID NO:3, SNP17, which comprises an A to C nucleotide substitution at position number 129 in SEQ ID NO:4, SNP19, which comprises an A to T nucleotide substitution at position number 173 in SEQ ID NO:5, SNP20, which comprises a G to A nucleotide substitution at position number 221 in SEQ ID NO:6, SNP22, which comprises a T to G nucleotide substitution at position number 160 in SEQ ID NO:7, and SNP24, which comprises a G to A nucleotide substitution at position number 325 in SEQ ID NO:8.
 2. The stevia plant of claim 1, wherein the leaves of said stevia plant have a rebaudioside D content of between 0.6% and 3.3% of dry weight.
 3. The stevia plant of claim 1, wherein the leaves of said stevia plant have a rebaudioside M content of between 0.5% and 1.15% of dry weight.
 4. The stevia plant of claim 1, wherein the leaves of said stevia plant have a rebaudioside D content of between 0.6% and 3.3% of dry weight, and a rebaudioside M content of between 0.5% and 1.15% of dry weight.
 5. The stevia plant of claim 1, further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein said isoforms correspond to SEQ ID NOs: 19-23, and isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein said isoforms correspond to SEQ ID NOs: 24-54, and wherein said stevia plant has high rebaudioside D content.
 6. The stevia plant of claim 1, further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein said isoforms correspond to SEQ ID NOs: 9-13, and isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein said isoforms correspond to SEQ ID NOs: 86-116, and wherein said stevia plant has high rebaudioside M content.
 7. The stevia plant of claim 1, further comprising isoforms of UDP-glucosyltransferase 76G1 (UGT76G1), wherein said isoforms correspond to SEQ ID NOs: 14-18, and isoforms of UDP-glucosyltransferase 91D2 (UGT91D2), wherein said isoforms correspond to SEQ ID NOs: 55-85, and wherein said stevia plant has high rebaudioside M content.
 8. The stevia plant of claim 6, wherein said stevia plant further comprises a high rebaudioside D content.
 9. The stevia plant of claim 7, wherein said stevia plant further comprises a high rebaudioside D content.
 10. A method of producing a commodity plant product, comprising obtaining the plant of claim 1, or a part thereof, and producing the commodity plant product from the plant or part thereof, wherein the commodity plant product is a composition of glycosides. 